Page last updated: 2024-09-05

dabigatran and Thromboembolism

dabigatran has been researched along with Thromboembolism in 324 studies

Research

Studies (324)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	17 (5.25)	29.6817
2010's	275 (84.88)	24.3611
2020's	32 (9.88)	2.80

Authors

Authors	Studies
Cheng, K; Li, S; Liao, C; Lv, X; Tian, Y; Xiao, X; Xie, Z; Zhan, M	1
An, J; Duan, L; Huang, CW; Lee, MS; Sim, JJ	1
Barnes, GD; DeCamillo, D; Haymart, B	1
Alioğlu, E; Altın, C; Bilgin, N; Çetin, N; Dalgıç, O; Ekmekçi, C; Kocabaş, U; Özpelit, ME; Pekel, N; Topaloğlu, C; Tülüce, K; Tunçer, E; Türk, UÖ; Türkoğlu, Eİ; Yavuz, V; Yüksel, K	1
Borgquist, R; Brandt, J; Farouq, M; Mörtsell, D; Wang, L	1
Archontakis-Barakakis, P; Batsidis, A; Giamouzis, G; Giannakoulas, G; Giannopoulos, S; Kalaitzoglou, D; Kokkinidis, DG; Li, W; Lip, GYH; Manolopoulos, A; Ntaios, G; Palaiodimos, L; Tzelves, L	1
Bielecka, B; Gorczyca-Głowacka, I; Wożakowska-Kapłon, B	1
Aronow, WS; Bahar, AR; Bahar, Y; Biswas, S; Gupta, R; Hajra, A; Mathai, SV; Safiriyu, I	1
Chen, X; Dai, H; Du, X; Gu, P; Guan, C; Huang, N; Huang, X; Li, R; Lin, X; Liu, X; Liu, Y; Lv, M; Wu, T; Xu, W; Zhang, J; Zhang, M; Zhang, W; Zheng, Q; Zhu, Z	1
Kwon, HM; Lee, YS; Moon, HS; Nam, KW; Won, SH	1
Achanta, A; Bhalodia, NJ; Cheng, J; Coons, JC; Deri, CR; Heiney, H; Iasella, CJ; Marchionda, O; Stahl, K; White, EM	1
Chu, CL; Dai, JW; Liao, SC; Wang, CH	1
Bos, MHA; den Exter, PL; Huisman, MV; Klok, FA; Martens, ESL; van der Horst, SFB; van Mens, TE	1
Cera, M; Comi, G; Cozzani, G; Della Bella, P; Gaspardone, C; Godino, C; Leo, G; Maisano, F; Margonato, A; Mattiello, P; Melillo, F; Montorfano, M; Nemola, G; Parlati, AL; Russi, A; Salerno, A; Sparasci, FM; Tresoldi, M; Vetrugno, L; Zangrillo, A	1
Elder, M; Hung, YC; Morris, A	1
Bhatt, DL; Cannon, CP; Hohnloser, SH; Kiss, RG; Kleine, E; Lip, GYH; Navarro Estrada, JL; Nickenig, G; Nordaby, M; Oldgren, J; Ongen, Z; Oude Ophuis, T; Steg, PG; Ten Berg, JM	1
Casajuana, M; Giner-Soriano, M; Morros, R; Roso-Llorach, A; Vedia, C	1
Barequet, IS; Bourla, N; Moisseiev, J; Salomon, O; Tamarin, I; Zehavi-Dorin, T	1
Devaraj, NK; Doris, G; Noraini, M; Sahimi, M; Shakirin, SR	1
Aiki, T; Aoyama, D; Fukuoka, Y; Hasegawa, K; Ikeda, H; Ishida, K; Ishikawa, E; Kaseno, K; Matsui, A; Miyahara, K; Miyazaki, S; Morishita, T; Mukai, M; Shiomi, Y; Tada, H; Tama, N; Uzui, H; Yamaguchi, J	1
Bhatt, DL; Cannon, CP; de Veer, A; Hohnloser, SH; Kimura, T; Lip, GYH; Miede, C; Nordaby, M; Oldgren, J; Steg, PG; Ten Berg, JM	1
Aimo, A; De Caterina, R; Petricciuolo, S	1
Buda, S; Degli Esposti, L; Perrone, V; Piovaccari, G; Saragoni, S	1
Alvarez, P; Asleh, R; Briasoulis, A; Chrischilles, E; Gao, Y; Inampudi, C; Leira, EC; Vaughan-Sarrazin, M	1
Chen, N; Holbrook, A; Lee, M; Leenus, A; Liu, J; Mbuagbaw, L; Thabane, L; Wang, M	1
Hirao, K; Hirao, T; Nakamura, RA; Oda, A; Okishige, K; Sasano, T; Shigeta, T; Tachibana, S; Yamauchi, Y; Yoshida, H	1
Berry, NC; Bhatt, DL; Cannon, CP; Hohnloser, SH; Kimura, T; Lip, GYH; Mauri, L; Miede, C; Nordaby, M; Oldgren, J; Steg, PG; Ten Berg, JM	1
Han, X; Ma, L; Nie, X; Peng, L; Wang, J; Zan, X; Zheng, N	1
Budnik, M; Chrapek, M; Filipiak, KJ; Gawałko, M; Gielerak, G; Gorczyca, I; Jelonek, O; Jurek, A; Kapłon-Cieślicka, A; Kiliszek, M; Kochanowski, J; Krzesiński, P; Michalska, A; Opolski, G; Scisło, P; Starzyk, K; Uziębło-Życzkowska, B; Wożakowska-Kapłon, B	1
Le, T; Pasciolla, S; Wright, K; Zizza, LF	1
Doyama, H; Fujishiro, M; Fujita, T; Hasatani, K; Hatta, W; Hiasa, Y; Hikichi, T; Igarashi, K; Iguchi, M; Inoue, T; Kawaguchi, K; Kitamura, K; Kuribayashi, S; Mikami, T; Morita, Y; Nishida, T; Nishikawa, J; Oda, I; Sumiyama, K; Sumiyoshi, T; Tomida, H; Tsuji, Y; Uraoka, T; Yada, T; Yamamoto, K; Yanagitani, A; Yoshio, T	1
Goya, M; Hirao, K; Kawabata, M; Maeda, S; Sasano, T; Takahashi, Y; Yagishita, A	1
Chen, S; Dong, Y; He, J; Lip, GYH; Liu, C; Wu, D; Ye, Z; Zhu, W	1
Chan, FK; Guo, CL; Lam, KL; Lau, LH; Mak, JW; Ng, SC; Wong, GL; Wong, SH; Yip, TC	1
Dong, YX; Gao, LJ; Li, WW; Ma, CM; Wang, N; Xia, YL; Xiao, XJ; Yang, MH; Yin, XM; Yu, XH; Zhang, RF	1
Pos, L	1
Chen, CY; Chu, CC; Huang, YL	1
Chan, NC; Eikelboom, JW; Xu, K	1
Di Pasquale, G; Riva, L	2
Grottke, O; Hofer, S; Lier, H	1
Barkun, AN; Dorreen, A; Huynh, T; Martel, M; Miller, CS	1
Beauchesne, MF; Blais, L; Brais, C; Farand, P; Larochelle, J; Letemplier, G; Perreault, S; Turgeon, MH	1
Barbera, V; Bellasi, A; Campana, C; Cozzolino, M; De Pascalis, A; Di Iorio, B; Di Lullo, L; Galliani, M; Ronco, C; Russo, D; Russo, L; Santoboni, F; Vitaliano, E	1
Andreas, M; Angleitner, P; Haberl, T; Laufer, G; Moayedifar, R; Riebandt, J; Schima, H; Schlöglhofer, T; Wiedemann, D; Wieselthaler, G; Wolzt, M; Zimpfer, D	2
Kemkes-Matthes, B	1
Asvestas, D; Bazoukis, G; Efremidis, M; Efremidis, T; Georgopoulos, S; Karamichalakis, N; Kolokathis, AM; Letsas, KP; Rokiza, A; Sakellaropoulou, A; Saplaouras, A; Sideris, A; Vlachos, K	1
Blennerhassett, R; Favaloro, EJ; Pasalic, L	1
Aiello, A; Aspromonte, N; Colivicchi, F; Di Fusco, SA; Santini, M; Tubaro, M	1
Kido, K; Scalese, MJ	1
Cheong, JS; Chung, JY; Kang, HG; Lee, SJ	1
Favaloro, EJ; Lippi, G; Pasalic, L	1
Jacobs, MS; Kappelhoff, B; Postma, MJ; Stevanovic, J; Tieleman, RG; van Hulst, M	1
Lim, GB	1
Godier, A; Martin, AC	1
Babiarz, A; Bodys, A; Budnik, M; Filipiak, KJ; Gawałko, M; Kapłon-Cieślicka, A; Kochanowski, J; Opolski, G; Peller, M; Scisło, P; Uliński, R; Żochowski, M	1
Collings, SL; Evans, D; Hack, G; Johnson, ME; Lefèvre, C; Maguire, A; Stynes, G	1
Heinrich-Nols, J; Kreuzer, J	1
Anguita, M; Asunción Esteve-Pastor, M; Bertomeu, V; Cequier, A; Marín, F; Martínez-Sellés, M; Muñiz, J; Raña Míguez, P; Roldán, I; Ruiz Ortiz, M	1
Ahn, Y; Cho, JG; Cho, JY; Hong, YJ; Hyun, DY; Jeong, MH; Kim, JH; Kim, KH; Kim, MC; Kim, Y; Lee, KH; Lee, N; Oh, SS; Park, HJ; Park, HW; Park, JC; Sim, DS; Won, J; Yoon, HJ; Yoon, NS	1
Miano, T; Pan, W; Uyhazi, KE; VanderBeek, BL	1
D'Onofrio, A; Golino, P; Nigro, G; Papa, AA; Rago, A; Russo, V	1
Johnsen, S; Lauvsnes, MB; Omdal, R	1
Cheng, HM; Hsu, CC; Hsu, PF; Huang, CJ; Sung, SH; Tu, ST; Yu, BH	1
Balsam, P; Bednarski, J; Filipiak, KJ; Grabowski, M; Kowalczuk, A; Kołtowski, Ł; Lodziński, P; Maciejewski, K; Opolski, G; Ozierański, K; Peller, M; Praska-Ogińska, A; Szepietowska, K; Tymińska, A; Zaboyska, I; Zaleska, M; Żukowska, K	1
Fischer, MA; Franklin, JM; Gagne, JJ; Glynn, RJ; Huybrechts, KF; Schneeweiss, S; Wang, SV	1
Antonucci, E; Cosmi, B; Dellanoce, C; Legnani, C; Morandini, R; Palareti, G; Paoletti, O; Pengo, V; Poli, D; Testa, R; Testa, S; Tripodi, A	1
Balsam, P; Bednarski, J; Maciejewski, K; Opolski, G; Ozierański, K; Peller, M; Praska-Oginska, A; Szepietowska, K; Tymińska, A; Zaboyska, I; Zaleska, M; Żukowska, K	1
de Boer, PT; Hoffmann, M; Jacobs, MS; Levin, LÅ; Postma, MJ; Schouten, JF	1
Beyer-Westendorf, I; Beyer-Westendorf, J; Endig, S; Marten, S; Reitter, A; Tittl, L	1
Chan, YH; Chang, SH; Kuo, CF; Kuo, CT; Lee, HF; See, LC; Tu, HT; Wang, CL; Wu, LS; Yeh, YH	1
Akintoye, E; Alvarez, P; Briasoulis, A; Inampudi, C; Panaich, S; Vaughan-Sarrazin, M	1
Dülgeroglu, J; Schmidt, D	1
Hart, A; Shroff, GR; Stoecker, R	1
Mohebbi, N	1
Alviz, I; Avendano, R; Cerna, L; Cerrud-Rodriguez, RC; Di Biase, L; Diaz, JC; Grupposo, V; Kirchhof, P; Kumar, S; Michaud, GF; Natale, A; Romero, J; Taveras, J	1
Ahuja, T; Green, D; Raco, V	1
Aizawa, Y; Fujita, S; Fuse, K; Ikeda, Y; Kitazawa, H; Okabe, M; Sato, T; Takahashi, M	1
Agnelli, G; Aita, A; Angeli, F; Becattini, C; Cavallini, C; Conti, S; Giustozzi, M; Molini, G; Turturiello, D; Vedovati, MC; Verdecchia, P	1
Alings, AMW; Huisman, MV; Klok, FA; Kruip, MJHA; Meijer, K; Simmers, TA; Te Boome, LCJ; Tieleman, R; van den Bemt, B; van der Wall, SJ; van Rein, N; Westerweel, PE	1
Chang, SH; Chu, PH; Kuo, CF; Tseng, HJ; Wang, CL; Wen, MS; Wu, VC	1
Birschmann, I; Blumenstock, G; Ebner, M; Härtig, F; Kuhn, J; Peter, A; Poli, S; Rupp, A; Spencer, C; Ziemann, U; Zuern, CS	1
Ashida, K; Fukuhara, E; Ishihara, M; Kishima, H; Masuyama, T; Mine, T	1
Hu, A; Niu, J; Winkelmayer, WC	1
Alcusky, M; Fisher, M; Goldberg, RJ; Hume, AL; Lapane, KL; McManus, DD; Tjia, J	1
Ayala-Paredes, F; Becker, G; Birnie, DH; Connolly, SJ; Coutu, B; Eikelboom, J; Essebag, V; Healey, JS; Kalfon, E; Lellouche, N; Nery, PB; Philippon, F; Sandhu, RK; Sapp, J; Sumner, GL; Verma, A; Wells, GA	1
Jafari, M; MacKay, J; Stecker, EC; Warden, BA; Willman, A	1
Dibiasi, C; Gratz, J; Wiegele, M	1
Atarashi, H; Fukaya, T; Inoue, H; Koretsune, Y; Okumura, K; Taniguchi, A; Uchiyama, S; Yamashita, T; Yasaka, M	1
Ay, C; Beer, R; Haushofer, A; Kwasny, O; Leitgeb, J; Ortler, M; Schaden, E; Schöchl, H; Wiegele, M	1
Jesus, P; Monteiro, JMC; Oliveira Filho, J; San-Martin, DL; Silva, BCG; Souza, IFB	1
Chan, YH; Chang, SH; Chen, SW; Kuo, CF; Kuo, CT; Lee, HF; See, LC; Tu, HT; Wu, LS; Yeh, YH	1
Attena, E; Calabrò, P; Crisci, M; D'Onofrio, A; Golino, P; Nigro, G; Papa, AA; Proietti, R; Rago, A; Rainone, C; Russo, V	1
Bhatt, DL; Brueckmann, M; Cannon, CP; Hohnloser, SH; Kimura, T; Kreuzer, J; Lip, GYH; Mauri, L; Miede, C; Montalescot, G; Nordaby, M; Oldgren, J; Ozkor, M; Steg, PG; Ten Berg, JM; Vardas, P	1
Aonuma, K; Goya, M; Harada, T; Hirao, K; Kihara, Y; Nakahara, S; Nakano, Y; Nogami, A; Nuruki, N; Origasa, H; Otani, R; Sekiguchi, Y; Yoshida, K; Yoshida, Y	1
Medlicott, NJ; Reith, D; Simpson, BH; Smith, A	1
Chan, YH; Chang, SH; Chao, TF; Kuo, CT; Lee, HF; Lip, GYH; See, LC; Tu, HT; Wu, LS; Yeh, YH	1
Akiyoshi, K; Goya, M; Hirao, K; Kawabata, M; Koyama, T; Maeda, S; Sekigawa, M; Takahashi, Y; Yagishita, A; Yamamoto, T	1
Boling, B; Nestor, MA	1
Camm, AJ	1
Buch, TN; Holm, J; Munck, LK	1
Apostolakis, S; Kasmeridis, C; Lip, GY	1
Abi-Saleh, B; Alam, S; Baranowski, B; Bassiouny, M; Borek, PP; Callahan, T; Chung, M; Diab, M; Dresing, T; Hussein, A; Kanj, M; Khoury, M; Lindsay, BD; Martin, DO; Niebauer, M; Rickard, J; Saliba, W; Sengupta, J; Sey, A; Shao, M; Tchou, PJ; Varma, N; Wazni, O	1
Stiefelhagen, P	1
Fujiwara, R; Fukuzawa, K; Hirata, K; Imamura, K; Itoh, M; Kiuchi, K; Matsumoto, A; Nakanishi, T; Suzuki, A; Takami, K; Takami, M; Takei, A; Yamashita, S; Yoshida, A	1
Bazargan, A; Douglas, G; McKenzie, JL	1
Nutescu, EA	1
Kalus, JS	1
Bauer, KA	1
Klein, HH	1
Amnueypol, M; Calkins, H; Haines, DE; Marchlinski, FE; Mead-Salley, M; Nademanee, K; Saklani, P; Salazar, M; Skanes, AC; Yarmohammadi, H; Zado, E	1
Hagen, G; Hamidi, V; Klemp, M; Reikvam, Å; Ringerike, T	1
Douketis, J; Liew, A	1
Rider, EB; Rider, OJ	1
Castillo, J; de Andrés, J; Ferrandis, R; Gomar, C; Gómez-Luque, A; Hidalgo, F; Llau, JV; Sierra, P; Torres, LM	1
Albenque, JP; Bouzeman, A; Boveda, S; Casteigt, B; Combes, N; Combes, S; Marijon, E; Narayanan, K; Providência, R	1
Atar, S; Brezins, M; Shtiwi, S; Shturman, A; Wishniak, A	1
Alexander, JH; Atwater, BD; Bahnson, TD; Daubert, JP; Hasselblad, V; Piccini, JP; Steinberg, BA; Washam, JB	1
Asirvatham, SJ; Noheria, A	1
Lip, GY; Potpara, TS	1
Bennaghmouch, N; Ten Berg, JM	1
Diener, HC; Easton, JD; Hankey, GJ; Hart, RG	1
Majeed, A; Schulman, S	1
Camm, AJ; Hohnloser, SH	1
Bahmaid, RA; Bin Abdulhak, AA; Garbati, MA; Khan, AR; Sanders, SU; Spertus, JA; Steigerwalt, KE; Tleyjeh, IM; Wimmer, AP	1
Hylek, EM	1
Blatchford, J; Brueckmann, M; Connolly, SJ; Devenny, K; Eikelboom, JW; Friedman, J; Granger, CB; Guiver, K; Harper, R; Kappetein, AP; Khder, Y; Lobmeyer, MT; Maas, H; Mack, MJ; Simoons, ML; Van de Werf, F; Voigt, JU	1
Kornej, J; Lip, GY; Potpara, T	1
Schulman, S	1
Bin Abdulhak, AA; Khan, AR; Tleyjeh, IM; Wimmer, AP	1
Waks, JW; Zimetbaum, PJ	1
Abe, K; Ito, J; Kawazoe, K; Kuwauchi, S; Watanabe, S; Yamasaki, M	1
Clemens, A; Connolly, SJ; Ferreira, J; Lip, GY; Noack, H; Yusuf, S	1
Albenque, JP; Boveda, S; Marijon, E; Providência, R	1
Atallah, R; Bloom, BJ; Eisenberg, MJ; Filion, KB	1
Bollmann, A; Breithardt, OA; Dinov, B; Doering, M; Hindricks, G; Kosiuk, J; Koutalas, E; Nedios, S; Richter, S; Rolf, S; Sommer, P	1
Aronow, WS; Chatterjee, S; Ghosh, J; Nairooz, R; Sardar, P; Wetterslev, J	1
Acket, B; Bagheri, H; Bourrel, R; Lavezzi, O; Molinier, A; Montastruc, JL	1
Albenque, JP; Boveda, S; Combes, N; Combes, S; Hireche, H; Jourda, F; Marijon, E; Morais, J; Providência, R	1
Fredenburgh, JC; Liao, P; Roberts, RS; Weitz, JI; Yau, JW	1
Groh, C; Passman, R; Yadlapati, A	1
Begg, EJ; Chin, PK; Doogue, MP; Patterson, DM; Wright, DF	1
Badhwar, N; Gerstenfeld, EP; Lee, BK; Lee, RJ; Marcus, GM; Olgin, J; Scheinman, M; Stepanyan, G; Tseng, ZH; Vedantham, V	1
Iung, B; Vahanian, A	1
Fenger-Eriksen, C; Grove, EL; Münster, AM	1
Ibrahim, S; Jespersen, J; Poller, L	1
Dempfle, CE	1
Aryal, MR; Bhandari, Y; Donato, A; Jalota, L; Karmacharya, P; Mainali, NR; Pandit, A; Pathak, R; Pradhan, R; Ukaigwe, A	1
Cowell, RP	1
Chatterjee, S; Halperin, JL; Herzog, E; Mukherjee, D; Nairooz, R; Sardar, P	1
Marciniak, ET; McCurdy, MT; Reed, RM; Weiler, B	1
Brand, S; Brueckmann, M; Clemens, A; Kansal, A; Lim, J; Noack, H; Peng, S; Sander, S; Sorensen, S	1
Engel, G; Kong, MH; Mead, RH; Patrawala, RA; Winkle, RA	2
Black, DF; McBane, RD; Moder, KG; Schaefer, JK; Williams, LN; Wysokinski, WE	1
Steurer, J	1
Barnes, GD; Eagle, KA; Froehlich, JB	1
Branch, J; Chuang, A; Cutler, TW; Huynh, TD; Pon, T; White, R; Witt, RG	1
Doering, M; Egidy, C; Gehrke, T; Kendoff, D; Krettek, C; Mommsen, P; R O Hrs, E	1
Ageno, W; Beyer-Westendorf, J	1
Berghold, A; Kemperdick, B; Mergenthal, K; Petersen, JJ; Rauck, S; Roehl, I; Schulz-Rothe, S; Siebenhofer, A; Ulrich, LR	1
Ansell, J; Bakhru, S; Costin, J; Laulicht, B; Steiner, S	1
Aita, A; Angeli, F; Bartolini, C; De Filippo, V; di Giacomo, L; Martone, S; Molini, G; Reboldi, G; Valecchi, F; Verdecchia, P	1
Beliavskaia, OO; Vavilova, TV	1
Feuerstein, JD; Ketwaroo, GA; Leffler, DA; Patwardhan, VR; Sengupta, N; Tapper, EB; Thaker, AM	1
Broncel, M; Ciastkowska, A; Duraj, I; Gorzelak-Pabiś, P; Szlagowska, L	1
Bultas, J; Karetová, D	1
Chang, SL; Chao, TF; Chen, SA; Chern, CM; Chung, FP; Hsu, LC; Hu, YF; Liao, JN; Lin, YJ; Lo, LW; Lu, TM; Sung, SH; Wang, KL; Weng, CH; Wu, CH	1
Levasseur-Franklin, KE; Liotta, EM; Naidech, AM	1
Cantillon, D; Coleman, CM; Kanj, M; Khalaf, S; Mould, S; Saliba, W; Wazni, O	1
Oberhofer, E	1
Chatelain, B; Devalet, B; Dogné, JM; Douxfils, J; Hjemdahl, P; Mullier, F; Pohanka, A; Rönquist-Nii, Y; Sennesael, AL; Wallemacq, P	1
Friedman, RJ; Messerschmidt, C	1
Aleil, B; Krieger, C; Stephan, D	1
Hogg, K; Weitz, JI; Yeh, CH	1
Hitos, K; Kumar, N; Phan, K; Pison, L; Thomas, SP; Wang, N	1
Castiblanco, SA; Garg, J; Jacobs, LE; Palaniswamy, C; Zak, M	1
Huh, J; Im, SI; Jeong, DS; Kim, JS; On, YK; Park, KM; Park, SJ	1
Abdollah, H; Baranchuk, A; Enriquez, A; Michael, K; Redfearn, D; Simpson, C	1
Arentz, T; Jadidi, A; Lehrmann, H; Park, CI; Pruvot, E; Weber, R; Zimmermann, M	1
Gehrie, E; Tormey, C	1
Beyer-Westendorf, J; Breslin, T; NiAinle, F; Werth, S	1
Barty, R; Blostein, M; Carrier, M; Douketis, JD; Heddle, N; Lee, AY; Schulman, S; Shivakumar, S; Solymoss, S; Spencer, FA; Wang, G	1
Bonde, AN; Fosbøl, EL; Gislason, GH; Hansen, ML; Lamberts, M; Lip, GY; Olesen, JB; Staerk, L; Torp-Pedersen, C	1
Alenholt, A; Engdahl, J; Fodor, E; Frick, M; Hagwall, K; Johansson, AK; Juhlin, T; Lind, S; Paul Nordin, A; Rorsman, C; Rosenqvist, M	1
Chatelain, B; Devalet, B; Dogné, JM; Douxfils, J; Mani, H; Minet, V; Mullier, F	1
Frische, C; Gawaz, M; Gramlich, M; Schreieck, J; Seizer, P	1
Crawford, B; Morimoto, T; Ueda, S; Wada, K	1
Alla, F; Billionnet, C; Blotière, PO; Bouillon, K; Maura, G; Ricordeau, P; Zureik, M	1
Goette, A; Hammwöhner, M	1
Bode, C; Kelm, M; Zeus, T	1
Chan, NC; Fredenburgh, JC; Jaffer, IH; Stafford, AR; Weitz, JI; Whitlock, RP	1
Grotts, J; Kaminski, S; Pozzessere, A	1
Riess, H	1
Gorbunova, EV; Mamchur, SE; Romanova, MP; Sherbinina, DA	1
Barty, R; Blostein, M; Chan, N; Douketis, JD; Eikelboom, JW; Moffat, KA; Schulman, S; Spencer, FA; Syed, S; Wang, G	1
Gislason, GH; Hansen, ML; Lindhardt, TB; Olesen, JB; Pallisgaard, JL; Schjerning, AM; Staerk, L; Torp-Pedersen, C	1
Bianchi, V; Calabrò, P; Cavallaro, C; D'Onofrio, A; De Vivo, S; Nigro, G; Russo, V; Santangelo, L; Sarubbi, B; Vecchione, F	1
Agirbasli, M; Atas, H; Bozbay, M; Cincin, A; Dogan, Z; Oguz, M; Sunbul, M	1
Holloway, C; Joseph, J; Perram, J	1
Andreu-Cayuelas, JM; Flores-Blanco, PJ; García-Alberola, A; Lip, GY; Manzano-Fernández, S; Mateo-Martínez, A; Pastor-Pérez, FJ; Puche, CM; Roldán, V; Valdés, M	1
Andersson, U; Aulin, J; Connolly, SJ; Ezekowitz, MD; Hijazi, Z; Huber, K; Oldgren, J; Reilly, PA; Siegbahn, A; Wallentin, L	1
Bertrand, M; Blotière, PO; Bouillon, K; Maura, G; Ricordeau, P; Zureik, M	1
Aonuma, K; Goya, M; Hirao, K; Nogami, A	1
Hussein, A; Saliba, W; Wazni, OM	1
How, CH	1
Hansen, PS; Sanchez, R; Walfridsson, H	1
Chin, PK; Fox, A; Marais, M; Tiong, J	1
Brueckmann, M; Connolly, SJ; Douketis, JD; Eikelboom, JW; Ezekowitz, MD; Fraessdorf, M; Healey, JS; Oldgren, J; Reilly, P; Spyropoulos, AC; Wallentin, L; Yusuf, S	1
Ayala-Paredes, F; Birnie, DH; Coutu, B; Coyle, D; Eikelboom, J; Essebag, V; Healey, JS; Kalfon, E; Nery, P; Philippon, F; Sandhu, RK; Sapp, J; Verma, A; Wells, G	1
Feng, Y; Li, PJ; Liang, ZA; Liu, GJ; Wang, T; Xiao, J; Yang, Q	1
Owusu, K; Reardon, DP	1
Eddings, W; Franklin, JM; Gagne, JJ; Glynn, RJ; Schneeweiss, S; Wang, SV	1
Cappato, R; De Caterina, R; Ezekowitz, MD; Giugliano, RP; Patel, MR; Piccini, JP; Renda, G; Ricci, F; Zimarino, M	1
Blinc, A; Gubenšek, M; Mavri, A; Pohar Perme, M; Tratar, G; Vene, N; Vižintin Cuderman, T	1
Sellke, FW; Sodha, NR	1
Ako, J; Fujiishi, T; Fukaya, H; Horiguchi, A; Igarashi, T; Ishizue, N; Kishihara, J; Murakami, M; Nakamura, H; Nishinarita, R; Niwano, S; Oikawa, J; Satoh, A; Yoshizawa, T	1
Chai, F; Ding, Y; Liu, X; Sun, L; Webster, TJ; Zhang, Y; Zheng, C	1
Berger, K; Lesch, CA; Sin, JH	1
Milling, TJ; Spyropoulos, AC	2
Peacock, WF; Villines, TC	1
Davies, RA; Orr, Y; Perera, NK	1
Chan, YH; Chang, SH; Kuo, CT; Lee, HF; See, LC; Tu, HT; Wu, LS; Yeh, YH	1
Henry, BL; Kumar, R; Rahman, AM	1
Falck, P; Fride Tvete, I; Ghanima, W; Halvorsen, S; Hoxmark, C; Jonasson, C; Solli, O	1
Buerke, M; Hoffmeister, HM	1
Weißbach, L; Zotz, RB	1
Darius, H	2
Broscaru, L; Gulba, DC	1
Felix, SB; Greinacher, A; Hammer, F; Selleng, K; Wernicke, S	1
Savina, NM	1
Fujisaki, J; Hirasawa, T; Horiuchi, Y; Igarashi, M; Ishiyama, A; Iwasaki, R; Michitaka, K; Mita, E; Ninomiya, T; Omae, M; Tomida, H; Tsuchida, T; Yamada, T; Yamamoto, Y; Yoshio, T	1
Plosker, GL; Sanford, M	1
Ieko, M; Nakabayashi, T; Nishio, H	1
Baetz, BE; Spinler, SA	1
Bounameaux, H	1
Halperin, JL	1
Heindl, B; Spannagl, M	1
Gogarten, W; Pauschert, R; Quante, M	1
Margieva, AV; Omel'ianovskiĭ, VV; Tsfasman, FM; Zagorodniĭ, NV	1
Barrios, V; Escobar, C; Jimenez, D	1
Alings, M; Connolly, SJ; Dans, A; Eikelboom, J; Ezekowitz, MD; Flather, M; Franzosi, MG; Oldgren, J; Pais, P; Pogue, J; Reilly, PA; Wallentin, L; Yang, S; Yusuf, S	1
Lane, DA; Lip, GY	1
Baumhäkel, M; Böhm, M; Schirmer, SH	1
Eikelboom, JW; Eriksson, BI; Quinlan, DJ	1
Cohen Arazi, H; Di Girolamo, G; Giorgi, MA; Gonzalez, CD	1
Bovio, JA; Gums, JG; Smith, SM	1
Khanna, V; Reynolds, M; Reynolds, MR; Rutzen-Lopez, H; Vkhanna, V	1
Ajzenberg, N; Dumont, B; Faille, D	1
Matziolis, D; Matziolis, G; Perka, C	1
Ezekowitz, MD; Nagarakanti, R	1
Kazmi, RS; Lwaleed, BA	1
Eckardt, L; Shin, DI	1
Turpie, AG	1
Mega, JL	1
Averkov, OV	1
Blais, DM; Boyd, JM; Hummel, J; Whitehead, H	1
Acharjee, S; Cannon, CP	1
Basset, T; Delavenne, X; Laporte, S; Mismetti, P; Moracchini, J	1
Alings, M; Connolly, SJ; Darius, H; Diener, HC; Eikelboom, J; Ezekowitz, MD; Kamensky, G; Oldgren, J; Reilly, PA; Wallentin, L; Yang, S; Yusuf, S	1
Golembiewski, JA	1
Garwood, CL; Hwang, JM; Moser, LR	1
Bode, C; Moser, M	1
Combe, S; Conard, J; Flaujac, C; Horellou, MH; Samamaa, MM	1
Redberg, RF	1
Jacobs, JM; Stessman, J	1
Hernandez, AV; Uchino, K	1
Afanas'eva, EV; Belousov, DIu; Belousov, IuB; Iavelov, IS; Mareev, VIu	1
Burkhardt, JD; Chalhoub, F; Coffey, J; D'Avila, A; Di Biase, L; Lakkireddy, D; Mansour, MC; Mohanty, P; Monir, G; Natale, A; Pimentel, R; Reddy, VY; Reddy, YM; Ruskin, J; Sanchez, JE; Santangeli, P; Shaik, N; Swarup, V; Vanga, SR	1
Giese, C; Harenberg, J; Krämer, R; Marx, S	1
Dahl, OE	1
Cheng, JW; Vu, H	1
Ahmed, S; Levin, V; Malacoff, R; Martinez, MW	1
Chatelain, B; Chatelain, C; Dogné, JM; Douxfils, J; Mullier, F; Spinewine, A; Sternotte, A	1
Haas, S; Schellong, SM; Spannagl, M	1
Little, JW	1
Freeman, MK; Hughes, PJ	1
Garcia, DA; Granger, CB	1
Avezum, A; Connolly, SJ; Douketis, J; Eikelboom, J; Ezekowitz, M; Healey, JS; Heidbuchel, H; Heidbuchle, H; Oldgren, J; Reilly, P; Themeles, E; Wallentin, L; Yang, S; Yusuf, S	1
Goel, R; Srivathsan, K	1
Brueckmann, M; Connolly, SJ; Eikelboom, JW; Friedman, J; Granger, CB; Harper, R; Härtter, S; Kappetein, AP; Lehr, T; Mack, MJ; Noack, H; Van de Werf, F	1
Ataullakhanov, FI; Panteleev, MA; Sinauridze, EI	1
Radecki, RP	1
Takahashi, N	1
Fuke, E; Hayano, M; Kaseno, K; Kumagai, K; Miki, Y; Naito, S; Nakamura, K; Nishiuchi, S; Oshima, S; Sakamoto, T; Sasaki, T; Tada, H; Tsukada, N; Yamashita, E	1
Grigor'ev, EV; Merkulov, IV; Momot, AP; Panov, MIu; Tsyvkina, LP	1
Crockett, MT; Kavanagh, EC; Moynagh, MR	1
Alonso-Coello, P; Guyatt, G; Zhou, Q	1
Lyrer, P; Nedeltchev, K; Seiffge, D	1
Strang, J; Travis, E	1
Douketis, JD; Gerotziafas, G; Kaatz, S; Ortel, TL; Schulman, S; Spyropoulos, AC	1
Alexander, GC; Kirley, K; Kornfield, R; Qato, DM; Stafford, RS	1
Brenner, B; Hoffman, R	1
Ellis, CR; Nagarakanti, R	1
Graf, L; Tsakiris, DA	1
Gonzalez, MD; Naccarelli, GV	1
Donato, G; Durin, O; Foffa, A; Inama, G; Nanetti, M	1
Valle Bernad, R	1
Nagler, M; Wuillemin, W	1
Haschke, M	1
Heinc, P; Hrčková, Y; Táborský, M	1
De Caterina, R; Renda, G	1
Ortel, TL	1
Bogun, F; Carrigan, T; Chugh, A; Crawford, T; Ghanbari, H; Good, E; Jongnarangsin, K; Kennedy, R; Kim, JS; Latchamsetty, R; Morady, F; Oral, H; Pelosi, F; Saint-Phard, W; She, F; Sinno, M; Suwanagool, A; Yokokawa, M	1
Pawlikowska, Z; Szponar, J	1
Kanorsky, SG; Shevelev, VI	1
Grove, EL; Husted, SE; Kraglund, KL; Modrau, B	1
Reynolds, C; Spinler, SA; To, K	1
Mungall, D	1
Ahnfelt, L; Dahl, OE; Eriksson, BI; Hermansson, K; Kälebo, P; Kohlbrenner, V; Nehmiz, G; Stangier, J	1
Ahnfelt, L; Bravo, ML; Büller, HR; Dahl, OE; Eriksson, BI; Hettiarachchi, R; Kälebo, P; Piovella, F; Reilly, P; Rosencher, N; Stangier, J	1
Bates, SM; Weitz, JI	1
Büller, HR; Di Nisio, M; Middeldorp, S	1
Eriksson, BI; Liesenfeld, KH; Schäfer, HG; Stangier, J; Tillmann, C; Trocóniz, IF	1
Ieko, M	1
Büller, HR; Dahl, OE; Eriksson, BI; Frostick, SP; Hantel, S; Hettiarachchi, R; Kurth, AA; Prins, MH; Rosencher, N; Schnee, J; van Dijk, CN	1
Ezekowitz, MD; Lionetti, DA; Nagarakanti, R; Nehmiz, G; Parcham-Azad, K; Pedersen, KE; Reilly, PA; Simmers, TA; Stangier, J; Wallentin, L	1

Reviews

119 review(s) available for dabigatran and Thromboembolism

Article	Year
The selectivity and bioavailability improvement of novel oral anticoagulants: An overview. European journal of medicinal chemistry, 2018, Feb-25, Volume: 146 Topics: Administration, Oral; Anticoagulants; Biological Availability; Humans; Thromboembolism	2018
Effectiveness and safety of intracranial events associated with the use of direct oral anticoagulants for atrial fibrillation: A systematic review and meta-analysis of 92 studies. British journal of clinical pharmacology, 2022, Volume: 88, Issue:11 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Brain Ischemia; Dabigatran; Humans; Intracranial Hemorrhages; Ischemic Stroke; Pyridones; Rivaroxaban; Stroke; Thromboembolism; Vitamin K	2022
Present Knowledge on Direct Oral Anticoagulant and Novel Oral Anti Coagulants and Their Specific Antidotes: A Comprehensive Review Article. Current problems in cardiology, 2023, Volume: 48, Issue:2 Topics: Administration, Oral; Anticoagulants; Antidotes; Dabigatran; Hemorrhage; Heparin; Humans; Thromboembolism	2023
Idarucizumab for dabigatran reversal: A systematic review and meta-analysis of indications and outcomes. Thrombosis research, 2023, Volume: 228 Topics: Antibodies, Monoclonal, Humanized; Antithrombins; Dabigatran; Hemorrhage; Hemostatics; Humans; Thromboembolism	2023
[Oral anticoagulation in patients with atrial fibrillation and stage 4 or 5 chronic kidney disease]. Giornale italiano di cardiologia (2006), 2020, Volume: 21, Issue:1 Topics: Administration, Oral; Age Factors; Aged; Anticoagulants; Atrial Fibrillation; Dabigatran; Diabetes Complications; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Hypertension; Male; Middle Aged; Off-Label Use; Prevalence; Pyrazoles; Pyridines; Pyridones; Renal Insufficiency, Chronic; Risk Factors; Rivaroxaban; Sex Factors; Sleep Apnea, Obstructive; Stroke; Thiazoles; Thromboembolism	2020
Barriers and facilitators to optimal oral anticoagulant management: a scoping review. Journal of thrombosis and thrombolysis, 2020, Volume: 50, Issue:3 Topics: Anticoagulants; Dabigatran; Disease Management; Factor Xa Inhibitors; Humans; Quality of Health Care; Rivaroxaban; Thromboembolism; Vitamin K; Warfarin	2020
Comparative Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients. Stroke, 2021, Volume: 52, Issue:4 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Humans; Observational Studies as Topic; Propensity Score; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thromboembolism	2021
Strategies for the prevention and treatment of bleeding in patients treated with dabigatran: an update. Expert opinion on drug metabolism & toxicology, 2021, Volume: 17, Issue:9 Topics: Antithrombins; Atrial Fibrillation; Dabigatran; Hemorrhage; Humans; Risk Factors; Thromboembolism	2021
[New oral anticoagulants in patients with atrial fibrillation: efficacy and safety data from the real world]. Giornale italiano di cardiologia (2006), 2017, Volume: 18, Issue:3 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Humans; Pyrazoles; Pyridines; Pyridones; Registries; Rivaroxaban; Thiazoles; Thromboembolism; Treatment Outcome	2017
[Management of hemorrhage in patients treated with direct oral anticoagulants]. Der Anaesthesist, 2017, Volume: 66, Issue:9 Topics: Administration, Oral; Antibodies, Monoclonal, Humanized; Anticoagulants; Antidotes; Dabigatran; Hemorrhage; Humans; Prothrombin; Thromboembolism	2017
Risk of Gastrointestinal Bleeding in Patients Taking Non-Vitamin K Antagonist Oral Anticoagulants: A Systematic Review and Meta-analysis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2017, Volume: 15, Issue:11 Topics: Anticoagulants; Dabigatran; Gastrointestinal Hemorrhage; Humans; Risk Assessment; Rivaroxaban; Stroke; Thromboembolism	2017
Nonvitamin K-dependent oral anticoagulants (NOACs) in chronic kidney disease patients with atrial fibrillation. Thrombosis research, 2017, Volume: 155 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Hemorrhage; Humans; Prospective Studies; Pyrazoles; Pyridines; Pyridones; Renal Insufficiency, Chronic; Rivaroxaban; Stroke; Thiazoles; Thromboembolism; Warfarin	2017
[Anticoagulation-direct oral anticoagulants]. Der Internist, 2017, Volume: 58, Issue:6 Topics: Administration, Oral; Anticoagulants; Antidotes; Atrial Fibrillation; Biological Availability; Body Weight; Dabigatran; Humans; Thromboembolism; Vitamin K	2017
Novel (Oral) Anticoagulant Challenges in Surgery. Seminars in thrombosis and hemostasis, 2017, Volume: 43, Issue:7 Topics: Administration, Oral; Anticoagulants; Dabigatran; Humans; Perioperative Period; Postoperative Complications; Pyrazoles; Pyridones; Rivaroxaban; Thromboembolism	2017
Direct oral anticoagulants in patients undergoing cardioversion: insight from randomized clinical trials. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, 2017, 05-18, Volume: 87, Issue:1 Topics: Administration, Oral; Anticoagulants; Antithrombins; Atrial Fibrillation; Dabigatran; Electric Countershock; Factor Xa Inhibitors; Hemorrhage; Humans; Incidence; Prospective Studies; Rivaroxaban; Stroke; Thromboembolism; Warfarin	2017
Management of Oral Anticoagulation Therapy After Gastrointestinal Bleeding: Whether to, When to, and How to Restart an Anticoagulation Therapy. The Annals of pharmacotherapy, 2017, Volume: 51, Issue:11 Topics: Anticoagulants; Dabigatran; Gastrointestinal Hemorrhage; Humans; Pyrazoles; Pyridones; Rivaroxaban; Thromboembolism; Warfarin	2017
Antithrombotic therapy: Dual therapy after PCI in AF. Nature reviews. Cardiology, 2017, Volume: 14, Issue:11 Topics: Antithrombins; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Dabigatran; Drug Therapy, Combination; Humans; Percutaneous Coronary Intervention; Purinergic P2Y Receptor Antagonists; Thromboembolism	2017
[Peri-Interventional Management of Direct Oral Anticoagulants - Balancing Benefits and Risks]. Praxis, 2018, Volume: 107, Issue:9-10 Topics: Administration, Oral; Aged; Antibodies, Monoclonal, Humanized; Anticoagulants; Atrial Fibrillation; Blood Coagulation Factors; Blood Coagulation Tests; Colonoscopy; Dabigatran; Factor Xa Inhibitors; Hemorrhage; Humans; Male; Premedication; Pyrazoles; Pyridines; Pyridones; Risk Assessment; Rivaroxaban; Thiazoles; Thromboembolism	2018
Non-Vitamin K-Dependent Oral Anticoagulants for Nonvalvular Atrial Fibrillation in Patients With CKD: Pragmatic Considerations for the Clinician. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2018, Volume: 72, Issue:5 Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Cyclophosphamide; Dabigatran; Diabetes Mellitus; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Hypertension; Male; Multimorbidity; Obesity; Prognosis; Pyrazoles; Pyridones; Renal Insufficiency, Chronic; Risk Assessment; Rivaroxaban; Thromboembolism	2018
[The Multimorbid Patient: Use of New Oral Anticoagulants in Patients with Chronic Kidney Disease]. Praxis, 2018, Volume: 107, Issue:13 Topics: Anticoagulants; Arterial Occlusive Diseases; Atrial Fibrillation; Comorbidity; Contraindications; Coronary Disease; Dabigatran; Glomerular Filtration Rate; Kidney Failure, Chronic; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thromboembolism; Vitamin K	2018
Uninterrupted direct oral anticoagulants vs. uninterrupted vitamin K antagonists during catheter ablation of non-valvular atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2018, 10-01, Volume: 20, Issue:10 Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Catheter Ablation; Cerebral Infarction; Dabigatran; Drug Administration Schedule; Factor Xa Inhibitors; Hemorrhage; Humans; Postoperative Complications; Postoperative Hemorrhage; Risk Factors; Rivaroxaban; Severity of Illness Index; Thromboembolism; Warfarin	2018
Oral Anticoagulation in Patients With End-Stage Kidney Disease on Dialysis and Atrial Fibrillation. Seminars in nephrology, 2018, Volume: 38, Issue:6 Topics: Anticoagulants; Atrial Fibrillation; Dabigatran; Humans; Kidney Failure, Chronic; Pyrazoles; Pyridines; Pyridones; Renal Dialysis; Rivaroxaban; Thiazoles; Thromboembolism; Warfarin	2018
Use of Direct Oral Anticoagulants Among Patients Undergoing Cardioversion: The Importance of Timing Before Cardioversion. Journal of the American Heart Association, 2018, 11-20, Volume: 7, Issue:22 Topics: Administration, Oral; Anticoagulants; Dabigatran; Electric Countershock; Humans; Pyrazoles; Pyridines; Pyridones; Risk Factors; Rivaroxaban; Thiazoles; Thromboembolism; Time Factors	2018
Reversing Direct Oral Anticoagulants in Acute Intracranial Hemorrhage. Critical care nurse, 2019, Volume: 39, Issue:3 Topics: Administration, Oral; Anticoagulants; Antithrombins; Benzamides; Dabigatran; Humans; Intracranial Hemorrhages; Practice Guidelines as Topic; Pyrazoles; Pyridines; Pyridones; Risk Assessment; Rivaroxaban; Thromboembolism; Treatment Outcome	2019
A new era of oral anticoagulation in atrial fibrillation: implications in clinical practice. Hospital practice (1995), 2013, Volume: 41, Issue:1 Topics: Administration, Oral; Adult; Age Distribution; Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Dabigatran; Hemorrhage; Humans; Middle Aged; Morpholines; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban; Stroke; Thiophenes; Thromboembolism; Warfarin	2013
Perioperative management of anticoagulation in elective surgery. ANZ journal of surgery, 2013, Volume: 83, Issue:11 Topics: Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Blood Loss, Surgical; Cardiovascular Diseases; Clopidogrel; Dabigatran; Elective Surgical Procedures; Humans; Perioperative Care; Platelet Aggregation Inhibitors; Postoperative Complications; Risk Assessment; Thromboembolism; Ticlopidine; Withholding Treatment	2013
Dabigatran, ROCKET atrial fibrillation, and beyond: basic science, mechanisms of agents, monitoring, and reversal. Stroke, 2013, Volume: 44, Issue:6 Suppl 1 Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Coagulation Factors; Cerebral Hemorrhage; Dabigatran; Factor Xa Inhibitors; Humans; Monitoring, Physiologic; Morpholines; Prodrugs; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Stroke; Thiophenes; Thrombin; Thromboembolism; Vitamin K; Warfarin	2013
[Electrical cardioversion for non-valvular atrial fibrillation--underestimated risk for thromboembolic complications?]. Deutsche medizinische Wochenschrift (1946), 2013, Volume: 138, Issue:24 Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Drug Administration Schedule; Electric Countershock; Enoxaparin; Heparin; Humans; International Normalized Ratio; Morpholines; Phenprocoumon; Practice Guidelines as Topic; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Risk Factors; Rivaroxaban; Stroke; Thiophenes; Thromboembolism; Warfarin	2013
New anticoagulants as thromboprophylaxis after total hip or knee replacement. International journal of technology assessment in health care, 2013, Volume: 29, Issue:3 Topics: Anticoagulants; Antithrombins; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles; beta-Alanine; Cost-Benefit Analysis; Dabigatran; Humans; Morpholines; Outcome Assessment, Health Care; Patient Safety; Premedication; Rivaroxaban; Thiophenes; Thromboembolism	2013
The changing face of oral anticoagulants. British dental journal, 2013, Volume: 215, Issue:1 Topics: Anticoagulants; Antithrombin Proteins; Benzimidazoles; Dabigatran; Factor Xa Inhibitors; Humans; Morpholines; Prodrugs; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiophenes; Thromboembolism; Warfarin	2013
The perioperative management of new direct oral anticoagulants: a question without answers. Thrombosis and haemostasis, 2013, Volume: 110, Issue:3 Topics: Administration, Oral; Aged; Anesthesiology; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles; beta-Alanine; Dabigatran; Female; Hemorrhage; Hemostasis; Heparin, Low-Molecular-Weight; Humans; Male; Morpholines; Patient Safety; Perioperative Period; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Thromboembolism	2013
Safety and efficacy of dabigatran versus warfarin in patients undergoing catheter ablation of atrial fibrillation: a systematic review and meta-analysis. Heart (British Cardiac Society), 2014, Volume: 100, Issue:4 Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Catheter Ablation; Dabigatran; Humans; Preoperative Care; Thromboembolism; Treatment Outcome; Warfarin	2014
Dabigatran for periprocedural anticoagulation following radiofrequency ablation for atrial fibrillation: a meta-analysis of observational studies. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2013, Volume: 37, Issue:3 Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Catheter Ablation; Comorbidity; Dabigatran; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Observational Studies as Topic; Postoperative Complications; Premedication; Risk Factors; Thromboembolism; Treatment Outcome	2013
Novel oral anticoagulants in non-valvular atrial fibrillation. Best practice & research. Clinical haematology, 2013, Volume: 26, Issue:2 Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials, Phase III as Topic; Dabigatran; Drug Administration Schedule; Humans; Intracranial Hemorrhages; Morpholines; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Thromboembolism	2013
New oral anticoagulants after acute coronary syndrome. Best practice & research. Clinical haematology, 2013, Volume: 26, Issue:2 Topics: Acute Coronary Syndrome; Administration, Oral; Aged; Anticoagulants; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Dabigatran; Factor Xa Inhibitors; Humans; Intracranial Hemorrhages; Morpholines; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Thrombin; Thromboembolism	2013
Novel oral anticoagulants in secondary prevention of stroke. Best practice & research. Clinical haematology, 2013, Volume: 26, Issue:2 Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Guidelines as Topic; Humans; Intracranial Hemorrhages; Morpholines; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Stroke; Thiophenes; Thromboembolism; Warfarin	2013
Bleeding and antidotes in new oral anticoagulants. Best practice & research. Clinical haematology, 2013, Volume: 26, Issue:2 Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Blood Coagulation Factors; Dabigatran; Drug Administration Schedule; Hemorrhage; Hemostatics; Humans; Morpholines; Prothrombin; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Thiazoles; Thiophenes; Thromboembolism	2013
Safety and efficacy of dabigatran etexilate during catheter ablation of atrial fibrillation: a meta-analysis of the literature. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2013, Volume: 15, Issue:10 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; Catheter Ablation; Chi-Square Distribution; Dabigatran; Hemorrhage; Humans; Odds Ratio; Pyridines; Risk Factors; Thromboembolism; Treatment Outcome; Warfarin	2013
Safety and efficacy of interrupted dabigatran for peri-procedural anticoagulation in catheter ablation of atrial fibrillation: a systematic review and meta-analysis. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2013, Volume: 15, Issue:10 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; Catheter Ablation; Chi-Square Distribution; Dabigatran; Drug Administration Schedule; Hemorrhage; Humans; Odds Ratio; Pyridines; Risk Factors; Thromboembolism; Treatment Outcome; Warfarin	2013
Anticoagulation management in nonvalvular atrial fibrillation: current and future directions. Polskie Archiwum Medycyny Wewnetrznej, 2013, Volume: 123, Issue:11 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Catheter Ablation; Dabigatran; Drug Administration Schedule; Fibrinolytic Agents; Forecasting; Humans; Morpholines; Percutaneous Coronary Intervention; Postoperative Care; Postoperative Hemorrhage; Premedication; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Thromboembolism; Warfarin	2013
Advantages and limitations of the new anticoagulants. Journal of internal medicine, 2014, Volume: 275, Issue:1 Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Blood Coagulation; Dabigatran; Disease Management; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Factor Xa Inhibitors; Humans; Intracranial Hemorrhages; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thiophenes; Thromboembolism	2014
Meta-analysis of randomized controlled trials on the risk of bleeding with dabigatran. The American journal of cardiology, 2014, Mar-15, Volume: 113, Issue:6 Topics: Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Global Health; Hemorrhage; Humans; Incidence; Randomized Controlled Trials as Topic; Risk Factors; Survival Rate; Thromboembolism	2014
Meta-analysis of risk of stroke or transient ischemic attack with dabigatran for atrial fibrillation ablation. The American journal of cardiology, 2014, Apr-01, Volume: 113, Issue:7 Topics: Administration, Oral; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Catheter Ablation; Dabigatran; Global Health; Humans; Incidence; Ischemic Attack, Transient; Stroke; Thromboembolism	2014
A proposal for dose-adjustment of dabigatran etexilate in atrial fibrillation guided by thrombin time. British journal of clinical pharmacology, 2014, Volume: 78, Issue:3 Topics: Atrial Fibrillation; Benzimidazoles; Dabigatran; Dose-Response Relationship, Drug; Drug Monitoring; Factor Xa Inhibitors; Hemorrhage; Humans; Pyridines; Thrombin Time; Thromboembolism	2014
New oral anticoagulants: clinical indications, monitoring and treatment of acute bleeding complications. Acta anaesthesiologica Scandinavica, 2014, Volume: 58, Issue:6 Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Blood Coagulation Tests; Dabigatran; Drug Monitoring; Factor Xa Inhibitors; Hemorrhage; Hemostatic Techniques; Hemostatics; Humans; Morpholines; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Thrombin; Thromboembolism; Thrombophilia	2014
Meta-analysis of efficacy and safety of rivaroxaban compared with warfarin or dabigatran in patients undergoing catheter ablation for atrial fibrillation. The American journal of cardiology, 2014, Aug-15, Volume: 114, Issue:4 Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Catheter Ablation; Dabigatran; Factor Xa Inhibitors; Humans; Morpholines; Rivaroxaban; Thiophenes; Thromboembolism; Treatment Outcome; Warfarin	2014
Direct oral anticoagulants: integration into clinical practice. Postgraduate medical journal, 2014, Volume: 90, Issue:1067 Topics: Acute Kidney Injury; Administration, Oral; Anticoagulants; Atrial Fibrillation; Clinical Trials, Phase III as Topic; Dabigatran; Drug Administration Schedule; Hemorrhage; Humans; Medication Adherence; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Thromboembolism; Treatment Outcome	2014
Novel oral anticoagulants in patients with renal insufficiency: a meta-analysis of randomized trials. The Canadian journal of cardiology, 2014, Volume: 30, Issue:8 Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Hemorrhage; Humans; Morpholines; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Renal Insufficiency; Rivaroxaban; Stroke; Thiophenes; Thromboembolism	2014
Perioperative management of oral anticoagulants: a focus on target-specific oral anticoagulants. Hospital practice (1995), 2014, Volume: 42, Issue:3 Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Drug Monitoring; Humans; Kidney Function Tests; Morpholines; Perioperative Period; Practice Guidelines as Topic; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Thromboembolism; Warfarin	2014
Benefit-risk profile of non-vitamin K antagonist oral anticoagulants in the management of venous thromboembolism. Thrombosis and haemostasis, 2015, Volume: 113, Issue:2 Topics: Administration, Oral; Anticoagulants; Blood Coagulation; Clinical Trials as Topic; Dabigatran; Factor Xa Inhibitors; Female; Hemorrhage; Heparin; Humans; Male; Orthopedic Procedures; Pyrazoles; Pyridines; Pyridones; Risk Assessment; Rivaroxaban; Thiazoles; Thromboembolism; Treatment Outcome; Venous Thromboembolism; Vitamin K	2015
Reversal agents in development for the new oral anticoagulants. Postgraduate medicine, 2014, Volume: 126, Issue:7 Topics: Antibodies, Monoclonal, Humanized; Anticoagulants; Antithrombins; Arginine; Benzimidazoles; beta-Alanine; Blood Coagulation Factors; Clinical Trials, Phase III as Topic; Dabigatran; Factor Xa; Factor Xa Inhibitors; Humans; Piperazines; Recombinant Proteins; Thromboembolism	2014
Reversal of the novel oral anticoagulants dabigatran, rivoraxaban, and apixaban. Current opinion in critical care, 2015, Volume: 21, Issue:2 Topics: Animals; Antidotes; Antithrombins; Benzimidazoles; beta-Alanine; Coagulants; Dabigatran; Factor Xa Inhibitors; Fibrinolytic Agents; Hemorrhage; Humans; Models, Animal; Morpholines; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Thromboembolism	2015
Clinical experience with novel oral anticoagulants for thromboprophylaxis after elective hip and knee arthroplasty. Arteriosclerosis, thrombosis, and vascular biology, 2015, Volume: 35, Issue:4 Topics: Administration, Oral; Anticoagulants; Antithrombins; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles; beta-Alanine; Dabigatran; Drug Administration Schedule; Elective Surgical Procedures; Factor Xa Inhibitors; Hemorrhage; Humans; Morpholines; Pyrazoles; Pyridones; Risk Factors; Rivaroxaban; Thiophenes; Thromboembolism; Treatment Outcome	2015
Overview of the new oral anticoagulants: opportunities and challenges. Arteriosclerosis, thrombosis, and vascular biology, 2015, Volume: 35, Issue:5 Topics: Administration, Oral; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dabigatran; Dose-Response Relationship, Drug; Drug Administration Schedule; Factor Xa Inhibitors; Female; Humans; Male; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Sensitivity and Specificity; Stroke; Thiazoles; Thiophenes; Thromboembolism; Warfarin	2015
Periprocedural Management of New Oral Anticoagulants in Atrial Fibrillation Ablation. Journal of cardiovascular pharmacology and therapeutics, 2015, Volume: 20, Issue:5 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Cardiac Catheterization; Catheter Ablation; Dabigatran; Factor Xa Inhibitors; Humans; Meta-Analysis as Topic; Rivaroxaban; Thromboembolism; Treatment Outcome; Warfarin	2015
Dabigatran for the prevention and treatment of thromboembolic disorders. Expert review of cardiovascular therapy, 2015, Volume: 13, Issue:5 Topics: Animals; Antithrombins; Atrial Fibrillation; Dabigatran; Drug Monitoring; Hemorrhage; Humans; Intracranial Hemorrhages; Stroke; Thromboembolism	2015
Novel oral anticoagulants: efficacy, laboratory measurement, and approaches to emergent reversal. Archives of pathology & laboratory medicine, 2015, Volume: 139, Issue:5 Topics: Administration, Oral; Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Blood Coagulation; Dabigatran; Drug Monitoring; Factor Xa Inhibitors; Hemorrhage; Humans; Laboratories; Morpholines; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Thromboembolism; Treatment Outcome; Warfarin	2015
Bleeding Risk, Management and Outcome in Patients Receiving Non-VKA Oral Anticoagulants (NOACs). American journal of cardiovascular drugs : drugs, devices, and other interventions, 2015, Volume: 15, Issue:4 Topics: Antithrombins; Clinical Trials as Topic; Dabigatran; Factor Xa Inhibitors; Hemorrhage; Humans; Outcome Assessment, Health Care; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban; Thromboembolism; Vitamin K	2015
Non-VKA Oral Anticoagulants: Accurate Measurement of Plasma Drug Concentrations. BioMed research international, 2015, Volume: 2015 Topics: Anticoagulants; Blood Coagulation; Dabigatran; Hemorrhage; Humans; Morpholines; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban; Thiophenes; Thromboembolism	2015
Comparative efficacy and safety of novel oral anticoagulants in patients with atrial fibrillation: A network meta-analysis with the adjustment for the possible bias from open label studies. Journal of cardiology, 2015, Volume: 66, Issue:6 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Azetidines; Benzylamines; Dabigatran; Hemorrhage; Humans; Myocardial Infarction; Odds Ratio; Oligosaccharides; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Stroke; Thiazoles; Thromboembolism; Treatment Outcome; Vitamin K	2015
The Impact of Novel Anticoagulants: Should All AF Patients Now Be Anticoagulated? Journal of cardiovascular pharmacology, 2015, Volume: 66, Issue:6 Topics: Animals; Anticoagulants; Antithrombins; Atrial Fibrillation; Blood Coagulation; Dabigatran; Hemorrhage; Humans; Rivaroxaban; Thromboembolism; Treatment Outcome; Warfarin	2015
[Prophylaxis of thromboembolism in atrial fibrillation: new oral anticoagulants and left atrial appendage closure]. Deutsche medizinische Wochenschrift (1946), 2015, Volume: 140, Issue:16 Topics: Anticoagulants; Atrial Appendage; Atrial Fibrillation; Atrial Flutter; Benzimidazoles; beta-Alanine; Combined Modality Therapy; Contraindications; Dabigatran; Hemorrhage; Morpholines; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban; Thiophenes; Thromboembolism; Vitamin K	2015
[Treatment of bleeding complications due to oral anticoagulant drugs]. Laryngo- rhino- otologie, 2015, Volume: 94, Issue:10 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Hemorrhage; Humans; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thromboembolism; Vitamin K	2015
Evolving strategies to prevent stroke and thromboembolism in nonvalvular atrial fibrillation. Cleveland Clinic journal of medicine, 2015, Volume: 82, Issue:12 Suppl 2 Topics: Anticoagulants; Aspirin; Atrial Appendage; Atrial Fibrillation; Dabigatran; Equipment and Supplies; Hemorrhage; Humans; Ligation; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thromboembolism; Warfarin	2015
Network meta-analysis of efficacy and safety of competitive oral anticoagulants in patients undergoing radiofrequency catheter ablation of atrial fibrillation. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2016, Volume: 46, Issue:3 Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Catheter Ablation; Causality; Comorbidity; Dabigatran; Female; Humans; Incidence; Male; Middle Aged; Postoperative Complications; Pyrazoles; Pyridones; Risk Factors; Rivaroxaban; Thromboembolism; Treatment Outcome; Vitamin K	2016
Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants After Cardioversion for Nonvalvular Atrial Fibrillation. The American journal of medicine, 2016, Volume: 129, Issue:10 Topics: Administration, Oral; Anticoagulants; Antithrombins; Atrial Fibrillation; Dabigatran; Electric Countershock; Hemorrhage; Humans; Odds Ratio; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thromboembolism; Treatment Outcome; Warfarin	2016
Re-Initiation of Dabigatran and Direct Factor Xa Antagonists After a Major Bleed. The American journal of medicine, 2016, Volume: 129, Issue:11S Topics: Antithrombins; Atrial Fibrillation; Dabigatran; Factor Xa Inhibitors; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Intracranial Hemorrhages; Pyrazoles; Pyridones; Recurrence; Risk Assessment; Rivaroxaban; Stroke; Thromboembolism	2016
Safety of Direct Oral Anticoagulants: Insights from Postmarketing Studies. The American journal of medicine, 2016, Volume: 129, Issue:11S Topics: Administration, Oral; Antithrombins; Atrial Fibrillation; Dabigatran; Hemorrhage; Humans; Product Surveillance, Postmarketing; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thromboembolism	2016
Do novel anticoagulant agents increase the risk of perioperative complications during implantable cardiac rhythm device insertion? Interactive cardiovascular and thoracic surgery, 2017, Volume: 24, Issue:1 Topics: Aged, 80 and over; Anticoagulants; Cardiac Surgical Procedures; Dabigatran; Defibrillators, Implantable; Humans; Intraoperative Complications; Male; Pacemaker, Artificial; Postoperative Complications; Rivaroxaban; Thromboembolism; Warfarin	2017
A Review of the Clinical Subgroup Analyses From the RE-LY Trial. Reviews in cardiovascular medicine, 2016, Volume: 17, Issue:1-2 Topics: Adult; Aged; Anticoagulants; Atrial Fibrillation; Dabigatran; Dose-Response Relationship, Drug; Female; Hemorrhage; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Stroke; Thromboembolism; Treatment Outcome; Warfarin	2016
Re-initiation of dabigatran and direct factor Xa antagonists after a major bleed. The American journal of emergency medicine, 2016, Volume: 34, Issue:11S Topics: Antithrombins; Clinical Decision-Making; Dabigatran; Factor Xa Inhibitors; Gastrointestinal Hemorrhage; Humans; Intracranial Hemorrhages; Practice Guidelines as Topic; Risk Assessment; Thromboembolism	2016
[Management of NOAK administration during invasive or surgical interventions : When and how to pause and when to restart?] Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2017, Volume: 112, Issue:2 Topics: Administration, Oral; Antibodies, Monoclonal, Humanized; Anticoagulants; Blood Loss, Surgical; Dabigatran; Drug Interactions; Half-Life; Humans; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Surgical Procedures, Operative; Thiazoles; Thromboembolism; Vitamin K	2017
[NOAC: Real-life data and the role of antidotes for the treatment of bleeding]. Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2017, Volume: 112, Issue:2 Topics: Aged; Antibodies, Monoclonal, Humanized; Anticoagulants; Antidotes; Dabigatran; Factor Xa; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Pyrazoles; Pyridones; Recombinant Proteins; Rivaroxaban; Stroke; Thromboembolism; Vitamin K; Warfarin	2017
[Modern Approaches to Prevention of Thromboembolic Complications in Patients With Nonvalvular Atrial Fibrillation With a Direct Thrombin Inhibitor Dabigatran]. Kardiologiia, 2016, Volume: 56, Issue:7 Topics: Antithrombins; Atrial Fibrillation; Dabigatran; Humans; Thromboembolism	2016
Dabigatran etexilate: an oral direct thrombin inhibitor for prophylaxis and treatment of thromboembolic diseases. Pharmacotherapy, 2008, Volume: 28, Issue:11 Topics: Animals; Anticoagulants; Atrial Fibrillation; Benzimidazoles; Clinical Trials as Topic; Dabigatran; Humans; Pyridines; Thrombin; Thromboembolism	2008
What can ongoing clinical trials of anticoagulants demonstrate? Journal of cardiovascular medicine (Hagerstown, Md.), 2009, Volume: 10, Issue:8 Topics: Anticoagulants; Azetidines; Benzimidazoles; Benzylamines; Clinical Trials as Topic; Dabigatran; Drugs, Investigational; Humans; Oligosaccharides; Pyridines; Thromboembolism; United States	2009
[New oral anticoagulants. Consequences for perioperative coagulation diagnostics and therapy]. Der Anaesthesist, 2009, Volume: 58, Issue:12 Topics: Administration, Oral; Anticoagulants; Benzimidazoles; Blood Coagulation Disorders; Dabigatran; Factor Xa Inhibitors; Humans; International Normalized Ratio; Intraoperative Complications; Morpholines; Partial Thromboplastin Time; Pyridines; Rivaroxaban; Thiophenes; Thrombin; Thromboembolism	2009
[Oral prevention of thromboembolism with rivaroxaban and dabigatran: are the newly approved drugs innovations in orthopaedic and trauma surgery? ]. Zeitschrift fur Orthopadie und Unfallchirurgie, 2010, Volume: 148, Issue:5 Topics: Administration, Oral; Benzimidazoles; beta-Alanine; Dabigatran; Fibrinolytic Agents; Humans; Morpholines; Orthopedic Procedures; Orthopedics; Practice Guidelines as Topic; Rivaroxaban; Thiophenes; Thromboembolism; Traumatology; Treatment Outcome	2010
Atrial fibrillation and dabigatran: has the time come to use new anticoagulants? Cardiovascular therapeutics, 2010, Volume: 28, Issue:5 Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Coagulation; Dabigatran; Hemorrhage; Humans; Risk Assessment; Thrombin; Thromboembolism; Treatment Outcome	2010
[Novel anticoagulants for stroke prevention in atrial fibrillation]. Deutsche medizinische Wochenschrift (1946), 2010, Volume: 135, Issue:46 Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Azetidines; Benzimidazoles; Benzylamines; Clinical Trials, Phase III as Topic; Dabigatran; Factor Xa Inhibitors; Fibrinolytic Agents; Humans; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiophenes; Thromboembolism	2010
Dabigatran etexilate (Pradaxa)--a new oral anticoagulant. The Medical letter on drugs and therapeutics, 2010, Nov-15, Volume: 52, Issue:1351 Topics: Administration, Oral; Animals; Anticoagulants; Antithrombin Proteins; Atrial Fibrillation; Benzimidazoles; Clinical Trials as Topic; Dabigatran; Hemorrhage; Humans; Prodrugs; Pyridines; Thromboembolism	2010
Novel oral factor Xa and thrombin inhibitors in the management of thromboembolism. Annual review of medicine, 2011, Volume: 62 Topics: Acute Coronary Syndrome; Amidines; Anticoagulants; Atrial Fibrillation; Azetidines; Benzimidazoles; Clinical Trials as Topic; Dabigatran; Factor Xa Inhibitors; Humans; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Thiophenes; Thrombin; Thromboembolism; Treatment Outcome; Vitamin K	2011
Changing anticoagulant paradigms for atrial fibrillation: dabigatran, apixaban and rivaroxaban. Expert opinion on pharmacotherapy, 2011, Volume: 12, Issue:4 Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Drug Design; Humans; Morpholines; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Thromboembolism; Vitamin K	2011
Dabigatran etexilate: a novel oral thrombin inhibitor for thromboembolic disease. The Annals of pharmacotherapy, 2011, Volume: 45, Issue:5 Topics: Antithrombin Proteins; Benzimidazoles; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dabigatran; Humans; Off-Label Use; Pyridines; Thrombin; Thromboembolism	2011
Atrial fibrillation: epidemiology, prognosis and therapy. Minerva medica, 2011, Volume: 102, Issue:3 Topics: Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Atrial Appendage; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Catheter Ablation; Dabigatran; Dronedarone; Electric Countershock; Heart Rate; Humans; Prognosis; Quality of Life; Risk Factors; Thromboembolism	2011
[New oral anticoagulant drugs: dabigatran, rivaroxaban and apixaban. Present and future]. Medecine sciences : M/S, 2011, Volume: 27, Issue:5 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Dabigatran; Drug Approval; Drug Monitoring; Factor Xa Inhibitors; Fibrinolytic Agents; Forecasting; France; Humans; Morpholines; Orthopedic Procedures; Postoperative Complications; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Thrombin; Thromboembolism; Thrombophilia; Venous Thromboembolism	2011
New anticoagulants: how to deal with treatment failure and bleeding complications. British journal of clinical pharmacology, 2011, Volume: 72, Issue:4 Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Hemorrhage; Humans; Morpholines; Rivaroxaban; Thiophenes; Thromboembolism; Thrombosis; Treatment Failure	2011
[New concepts in the therapy of atrial fibrillation]. Deutsche medizinische Wochenschrift (1946), 2011, Volume: 136, Issue:31-32 Topics: Anisoles; Anti-Arrhythmia Agents; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Catheter Ablation; Dabigatran; Electric Countershock; Humans; Pacemaker, Artificial; Pyrrolidines; Stroke; Thromboembolism	2011
Rivaroxaban for the prevention and treatment of venous thromboembolism. Fundamental & clinical pharmacology, 2012, Volume: 26, Issue:1 Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles; Clinical Trials, Phase III as Topic; Dabigatran; Humans; Medication Adherence; Morpholines; Practice Guidelines as Topic; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiophenes; Thromboembolism	2012
[Atrial fibrillation: novel possibilities of anticoagulant therapy in patients subjected to cardioversion]. Kardiologiia, 2011, Volume: 51, Issue:7 Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Drug Monitoring; Echocardiography, Three-Dimensional; Electric Countershock; Humans; International Normalized Ratio; Premedication; Randomized Controlled Trials as Topic; Risk Adjustment; Thromboembolism; Time Factors; Warfarin	2011
[Thromboembolic prophylaxis 2011: is warfarin on the wane?]. Giornale italiano di cardiologia (2006), 2011, Volume: 12, Issue:9 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzamides; Benzimidazoles; beta-Alanine; Clinical Trials, Phase III as Topic; Dabigatran; Evidence-Based Medicine; Humans; Morpholines; Pyrazoles; Pyridines; Pyridones; Risk Assessment; Rivaroxaban; Thiazoles; Thiophenes; Thromboembolism; Treatment Outcome; Warfarin	2011
Dabigatran: a new option for anticoagulation in atrial fibrillation and venous thromboembolism. Critical pathways in cardiology, 2011, Volume: 10, Issue:2 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Biopharmaceutics; Blood Coagulation; Clinical Trials, Phase III as Topic; Dabigatran; Drug Approval; Drug Dosage Calculations; Drug Monitoring; Humans; Risk Assessment; Therapeutic Equivalency; Thrombin; Thromboembolism; Warfarin	2011
Striking a balance between the risks and benefits of anticoagulation bridge therapy in patients with atrial fibrillation: clinical updates and remaining controversies. Pharmacotherapy, 2011, Volume: 31, Issue:12 Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Humans; International Normalized Ratio; Perioperative Care; Stroke; Thromboembolism; Vitamin K	2011
Dabigatran association with higher risk of acute coronary events: meta-analysis of noninferiority randomized controlled trials. Archives of internal medicine, 2012, Mar-12, Volume: 172, Issue:5 Topics: Acute Coronary Syndrome; Adult; Benzimidazoles; beta-Alanine; Dabigatran; Female; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Thromboembolism	2012
Determination of dabigatran in human plasma samples. Seminars in thrombosis and hemostasis, 2012, Volume: 38, Issue:1 Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Thromboembolism	2012
New oral antithrombotics: focus on dabigatran, an oral, reversible direct thrombin inhibitor for the prevention and treatment of venous and arterial thromboembolic disorders. Vascular health and risk management, 2012, Volume: 8 Topics: Administration, Oral; Animals; Antithrombins; Arterial Occlusive Diseases; Benzimidazoles; beta-Alanine; Blood Coagulation; Dabigatran; Fibrinolytic Agents; Humans; Risk Factors; Thromboembolism; Treatment Outcome; Venous Thromboembolism	2012
Dabigatran etexilate: an oral direct thrombin inhibitor for the management of thromboembolic disorders. Clinical therapeutics, 2012, Volume: 34, Issue:4 Topics: Adult; Aged; Area Under Curve; Benzimidazoles; Biological Availability; Dabigatran; Female; Humans; Male; Prodrugs; Pyridines; Randomized Controlled Trials as Topic; Thromboembolism	2012
Dabigatran: a new chapter in anticoagulation. Cardiovascular & hematological agents in medicinal chemistry, 2012, Volume: 10, Issue:2 Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Dabigatran; Dose-Response Relationship, Drug; Food-Drug Interactions; Humans; Molecular Structure; Stroke; Thromboembolism; Treatment Outcome	2012
[Clinical studies, the interests and limits of using dabigatran in atrial fibrillation]. Journal de pharmacie de Belgique, 2012, Issue:1 Topics: Aged; Anti-Arrhythmia Agents; Anticoagulants; Antidotes; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dabigatran; Female; Humans; Male; Monitoring, Physiologic; Platelet Aggregation; Stroke; Thromboembolism; Warfarin	2012
Novel oral anticoagulants--key messages for the angiologist. VASA. Zeitschrift fur Gefasskrankheiten, 2012, Volume: 41, Issue:3 Topics: Administration, Oral; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; Blood Coagulation; Blood Coagulation Tests; Dabigatran; Drug Monitoring; Evidence-Based Medicine; Factor Xa Inhibitors; Hemorrhage; Humans; Morpholines; Practice Guidelines as Topic; Predictive Value of Tests; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiophenes; Thrombin; Thromboembolism	2012
New oral anticoagulants: will they replace warfarin? Oral surgery, oral medicine, oral pathology and oral radiology, 2012, Volume: 113, Issue:5 Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Drug Hypersensitivity; Drug Interactions; Factor Xa Inhibitors; Gastritis; Hemorrhage; Humans; Liver; Morpholines; Rivaroxaban; Thiophenes; Thromboembolism	2012
Newer oral anticoagulant agents: a new era in medicine. Current cardiology reviews, 2012, Volume: 8, Issue:2 Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Factor Xa Inhibitors; Humans; Morpholines; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Thromboembolism	2012
Anticoagulant therapy: basic principles, classic approaches and recent developments. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2012, Volume: 23, Issue:6 Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Blood Coagulation; Dabigatran; Factor Xa; Factor Xa Inhibitors; Heparin, Low-Molecular-Weight; Hirudins; Humans; Platelet Aggregation Inhibitors; Thrombin; Thromboembolism; Thrombophilia; Venous Thrombosis; Vitamin K; Warfarin	2012
The novel oral anticoagulants: an update for the interventional radiologist. AJR. American journal of roentgenology, 2012, Volume: 199, Issue:3 Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Blood Coagulation; Dabigatran; Factor Xa Inhibitors; Humans; Morpholines; Pyrazoles; Pyridones; Radiography, Interventional; Rivaroxaban; Thiophenes; Thromboembolism	2012
Home-monitoring of oral anticoagulation vs. dabigatran. An indirect comparison. Thrombosis and haemostasis, 2012, Volume: 108, Issue:4 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Drug Monitoring; Hemorrhage; Humans; Monitoring, Ambulatory; Self Care; Stroke; Thromboembolism; Vitamin K; Warfarin	2012
[The new anticoagulants - their role in secondary prevention of thromboembolism after stroke]. Therapeutische Umschau. Revue therapeutique, 2012, Volume: 69, Issue:9 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Humans; International Normalized Ratio; Morpholines; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Secondary Prevention; Stroke; Thiophenes; Thromboembolism; Vitamin K	2012
Periprocedural antithrombotic and bridging therapy: recommendations for standardized reporting in patients with arterial indications for chronic oral anticoagulant therapy. Journal of thrombosis and haemostasis : JTH, 2012, Volume: 10, Issue:4 Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Elective Surgical Procedures; Factor Xa Inhibitors; Fibrinolytic Agents; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Ischemic Attack, Transient; Medical Records; Morpholines; Perioperative Period; Pyrazoles; Pyridines; Pyridones; Risk Assessment; Rivaroxaban; Stroke; Thiazoles; Thiophenes; Thromboembolism	2012
The promise of novel direct oral anticoagulants. Best practice & research. Clinical haematology, 2012, Volume: 25, Issue:3 Topics: Anticoagulants; Antithrombins; Azetidines; Benzimidazoles; Benzylamines; Clinical Trials, Phase III as Topic; Dabigatran; Factor Xa Inhibitors; Heparin, Low-Molecular-Weight; Humans; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thiophenes; Thrombin; Thromboembolism; Warfarin	2012
Dabigatran in clinical practice. Clinical therapeutics, 2012, Volume: 34, Issue:10 Topics: Administration, Oral; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; Dabigatran; Dose-Response Relationship, Drug; Humans; International Normalized Ratio; Pyridines; Stroke; Thromboembolism; Warfarin	2012
Anticoagulant treatment: the end of the old agents? Swiss medical weekly, 2012, Volume: 142 Topics: Acute Coronary Syndrome; Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Drug Interactions; Factor Xa Inhibitors; Humans; Morpholines; Prothrombin; Rivaroxaban; Stroke; Thiophenes; Thromboembolism	2012
[Laboratory diagnostic with regard to new anticoagulants - monitoring and influence on coagulation tests]. Therapeutische Umschau. Revue therapeutique, 2012, Volume: 69, Issue:11 Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Blood Coagulation; Blood Coagulation Tests; Dabigatran; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Food-Drug Interactions; Hemostasis; Humans; Morpholines; Pyrazoles; Pyridones; Rivaroxaban; Switzerland; Thiophenes; Thromboembolism	2012
[Clinical pharmacological aspects of new oral anticoagulants]. Therapeutische Umschau. Revue therapeutique, 2012, Volume: 69, Issue:11 Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dabigatran; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Factor Xa Inhibitors; Hemorrhage; Humans; Metabolic Clearance Rate; Morpholines; Pyrazoles; Pyridones; Risk Factors; Rivaroxaban; Thiophenes; Thromboembolism; Vitamin K	2012
[Dabigatran etexilate in clinical practice for prevention of thromboembolic events in patients with atrial fibrillation]. Vnitrni lekarstvi, 2012, Volume: 58, Issue:10 Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; Dabigatran; Humans; Pyridines; Thromboembolism	2012
Perioperative management of patients on chronic antithrombotic therapy. Hematology. American Society of Hematology. Education Program, 2012, Volume: 2012 Topics: Administration, Oral; Aged; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Fibrinolytic Agents; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; International Normalized Ratio; Middle Aged; Morpholines; Perioperative Care; Risk; Rivaroxaban; Thiophenes; Thromboembolism; Thrombosis; Vitamin K	2012
[New anticoagulants--are we prepared?]. Przeglad lekarski, 2012, Volume: 69, Issue:8 Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Factor Xa Inhibitors; Hemorrhage; Humans; Morpholines; Prothrombin; Rivaroxaban; Thiophenes; Thromboembolism	2012
[Anticoagulant therapy in stroke patients]. Ugeskrift for laeger, 2013, Jan-28, Volume: 175, Issue:5 Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Brain Ischemia; Cerebral Hemorrhage; Dabigatran; Female; Humans; Male; Morpholines; Pyrazoles; Pyridones; Radiography; Risk Assessment; Risk Factors; Secondary Prevention; Stroke; Thiophenes; Thromboembolism; Vitamin K	2013
BIBR-1048 Boehringer Ingelheim. Current opinion in investigational drugs (London, England : 2000), 2002, Volume: 3, Issue:6 Topics: Animals; Benzimidazoles; Brain Ischemia; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Dabigatran; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrinolytic Agents; Humans; Prodrugs; Pyridines; Structure-Activity Relationship; Thromboembolism; Venous Thrombosis	2002
New anticoagulants. Journal of thrombosis and haemostasis : JTH, 2005, Volume: 3, Issue:8 Topics: Animals; Anticoagulants; Azetidines; Benzimidazoles; Benzylamines; Blood Coagulation; Blood Coagulation Factors; Dabigatran; Factor IX; Fibrinolytic Agents; Humans; Models, Biological; Protein C; Pyridines; Thrombin; Thromboembolism; Venous Thrombosis	2005
Dabigatran etexilate, a thrombin inhibitor for the prevention of venous thromboembolism and stroke. Current opinion in investigational drugs (London, England : 2000), 2007, Volume: 8, Issue:9 Topics: Animals; Benzimidazoles; Dabigatran; Fibrinolytic Agents; Humans; Molecular Structure; Patents as Topic; Prodrugs; Pyridines; Stroke; Structure-Activity Relationship; Thrombin; Thromboembolism; Treatment Outcome; Venous Thrombosis	2007

Trials

29 trial(s) available for dabigatran and Thromboembolism

Article	Year
Renal Function and Outcomes With Dabigatran Dual Antithrombotic Therapy in Atrial Fibrillation Patients After PCI. JACC. Cardiovascular interventions, 2019, 08-26, Volume: 12, Issue:16 Topics: Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Coronary Artery Disease; Dabigatran; Drug Therapy, Combination; Female; Fibrinolytic Agents; Hemorrhage; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prospective Studies; Risk Factors; Thromboembolism; Time Factors; Treatment Outcome; Warfarin	2019
Feasibility of Uninterrupted Direct Oral Anticoagulants with Temporary Switching to Dabigatran ("Dabigatran Bridge") for Catheter Ablation of Atrial Fibrillation. International heart journal, 2019, Nov-30, Volume: 60, Issue:6 Topics: Administration, Oral; Aged; Antithrombins; Atrial Fibrillation; Catheter Ablation; Clinical Protocols; Dabigatran; Drug Administration Schedule; Feasibility Studies; Female; Humans; Male; Middle Aged; Partial Thromboplastin Time; Postoperative Complications; Thromboembolism	2019
Effect of Lesion Complexity and Clinical Risk Factors on the Efficacy and Safety of Dabigatran Dual Therapy Versus Warfarin Triple Therapy in Atrial Fibrillation After Percutaneous Coronary Intervention: A Subgroup Analysis From the REDUAL PCI Trial. Circulation. Cardiovascular interventions, 2020, Volume: 13, Issue:4 Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Dabigatran; Dual Anti-Platelet Therapy; Female; Hemorrhage; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prospective Studies; Risk Assessment; Risk Factors; Stents; Thromboembolism; Ticagrelor; Time Factors; Treatment Outcome; Warfarin	2020
Appropriate intraprocedural initial heparin dosing in patients undergoing catheter ablation for atrial fibrillation receiving uninterrupted non-vitamin-K antagonist oral anticoagulant treatment. BMC cardiovascular disorders, 2021, 04-27, Volume: 21, Issue:1 Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Catheter Ablation; China; Dabigatran; Double-Blind Method; Drug Administration Schedule; Drug Monitoring; Female; Heparin; Humans; Male; Middle Aged; Postoperative Hemorrhage; Prospective Studies; Risk Assessment; Risk Factors; Rivaroxaban; Stroke; Thromboembolism; Time Factors; Treatment Outcome; Warfarin; Whole Blood Coagulation Time	2021
Increased Thromboembolic Events With Dabigatran Compared With Vitamin K Antagonism in Left Ventricular Assist Device Patients: A Randomized Controlled Pilot Trial. Circulation. Heart failure, 2017, Volume: 10, Issue:5 Topics: Antithrombins; Dabigatran; Dose-Response Relationship, Drug; Equipment Failure; Female; Follow-Up Studies; Heart Ventricles; Heart-Assist Devices; Humans; Male; Middle Aged; Phenprocoumon; Pilot Projects; Prospective Studies; Thromboembolism; Time Factors; United States; Vitamin K	2017
Direct oral anticoagulants in patients undergoing cardioversion: insight from randomized clinical trials. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, 2017, 05-18, Volume: 87, Issue:1 Topics: Administration, Oral; Anticoagulants; Antithrombins; Atrial Fibrillation; Dabigatran; Electric Countershock; Factor Xa Inhibitors; Hemorrhage; Humans; Incidence; Prospective Studies; Rivaroxaban; Stroke; Thromboembolism; Warfarin	2017
Comparison of clinical characteristics of real-life atrial fibrillation patients treated with vitamin K antagonists, dabigatran, and rivaroxaban: results from the CRAFT study. Kardiologia polska, 2018, Volume: 76, Issue:5 Topics: Acenocoumarol; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Dabigatran; Female; Hemorrhage; Humans; Male; Middle Aged; Retrospective Studies; Rivaroxaban; Thromboembolism; Warfarin	2018
Impact of BMI on clinical outcomes of NOAC therapy in daily care - Results of the prospective Dresden NOAC Registry (NCT01588119). International journal of cardiology, 2018, 07-01, Volume: 262 Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Body Mass Index; Dabigatran; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Obesity; Prospective Studies; Pyrazoles; Pyridines; Pyridones; Registries; Rivaroxaban; Thiazoles; Thromboembolism; Treatment Outcome; Vitamin K	2018
Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2). European heart journal, 2018, 11-21, Volume: 39, Issue:44 Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Cardiac Pacing, Artificial; Dabigatran; Defibrillators, Implantable; Drug Administration Schedule; Female; Hematoma; Humans; Length of Stay; Male; Middle Aged; Postoperative Complications; Pyrazoles; Pyridones; Reoperation; Rivaroxaban; Thromboembolism	2018
Relationship of stroke and bleeding risk profiles to efficacy and safety of dabigatran dual therapy versus warfarin triple therapy in atrial fibrillation after percutaneous coronary intervention: An ancillary analysis from the RE-DUAL PCI trial. American heart journal, 2019, Volume: 212 Topics: Aged; Anticoagulants; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Dabigatran; Drug Therapy, Combination; Equivalence Trials as Topic; Female; Hemorrhage; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Risk Assessment; Stroke; Thromboembolism; Ticagrelor; Warfarin	2019
Safety and Efficacy of Minimally Interrupted Dabigatran vs Uninterrupted Warfarin Therapy in Adults Undergoing Atrial Fibrillation Catheter Ablation: A Randomized Clinical Trial. JAMA network open, 2019, 04-05, Volume: 2, Issue:4 Topics: Aged; Anticoagulants; Antithrombins; Atrial Fibrillation; Catheter Ablation; Dabigatran; Embolism; Female; Hemorrhage; Humans; Incidence; Japan; Male; Middle Aged; Perioperative Period; Prospective Studies; Thromboembolism; Treatment Outcome; Warfarin	2019
Dabigatran versus warfarin anticoagulation before and after catheter ablation for the treatment of atrial fibrillation. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2013, Volume: 37, Issue:3 Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Canada; Catheter Ablation; Comorbidity; Dabigatran; Decision Making; Drug-Related Side Effects and Adverse Reactions; Evidence-Based Medicine; Humans; Postoperative Complications; Premedication; Risk Factors; Thromboembolism; Treatment Outcome; United States; Warfarin	2013
Dabigatran versus warfarin in patients with mechanical heart valves. The New England journal of medicine, 2013, Sep-26, Volume: 369, Issue:13 Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Female; Heart Valve Prosthesis; Hemorrhage; Humans; Male; Middle Aged; Stroke; Thromboembolism; Warfarin	2013
Warfarin or dabigatran for treatment of atrial fibrillation. Journal of thrombosis and haemostasis : JTH, 2014, Volume: 12, Issue:7 Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Europe; Hemorrhage; Humans; Software; Thromboembolism; Warfarin	2014
[Comparison of the safety of rivaroxaban versus dabigatran therapy in patients with persistent atrial fibrillation]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2014, Volume: 37, Issue:221 Topics: Aged; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Factor Xa Inhibitors; Female; Gastrointestinal Diseases; Hemorrhage; Humans; Male; Morpholines; Rivaroxaban; Thiophenes; Thromboembolism	2014
Identification and management of noncompliance in atrial fibrillation patients receiving dabigatran: the role of a drug monitor. Pacing and clinical electrophysiology : PACE, 2015, Volume: 38, Issue:4 Topics: Aged; Antithrombins; Atrial Fibrillation; Dabigatran; Drug Monitoring; Female; Humans; Male; Medication Adherence; Reproducibility of Results; Sensitivity and Specificity; Thromboembolism; Treatment Outcome	2015
Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillation. American heart journal, 2015, Volume: 170, Issue:6 Topics: Aged; Anticoagulants; Atrial Fibrillation; Biomarkers; C-Reactive Protein; Dabigatran; Female; Hemorrhage; Humans; Interleukin-6; Male; Myocardial Infarction; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Risk Assessment; Stroke; Thromboembolism; Warfarin	2015
Ablation perioperative dabigatran in use envisioning in Japan: The ABRIDGE-J Study Design. Journal of cardiology, 2016, Volume: 68, Issue:3 Topics: Aged; Antithrombins; Atrial Fibrillation; Catheter Ablation; Dabigatran; Female; Hemorrhage; Humans; Male; Middle Aged; Perioperative Care; Prospective Studies; Thromboembolism; Warfarin	2016
Safety of novel oral anticoagulants in catheter ablation of atrial fibrillation. Danish medical journal, 2016, Volume: 63, Issue:2 Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Catheter Ablation; Dabigatran; Female; Humans; Male; Middle Aged; Postoperative Hemorrhage; Prospective Studies; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban; Thromboembolism	2016
Strategy of continued vs interrupted novel oral anticoagulant at time of device surgery in patients with moderate to high risk of arterial thromboembolic events: The BRUISE CONTROL-2 trial. American heart journal, 2016, Volume: 173 Topics: Administration, Oral; Anticoagulants; Arrhythmias, Cardiac; Canada; Cause of Death; Dabigatran; Defibrillators, Implantable; Dose-Response Relationship, Drug; Hemorrhage; Humans; Incidence; Pacemaker, Artificial; Practice Guidelines as Topic; Preoperative Care; Prospective Studies; Pyrazoles; Pyridones; Rivaroxaban; Survival Rate; Thromboembolism; Warfarin	2016
Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial. Lancet (London, England), 2010, Sep-18, Volume: 376, Issue:9745 Topics: Administration, Oral; Adult; Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; Dabigatran; Drug Administration Schedule; Female; Hemorrhage; Humans; International Normalized Ratio; Male; Middle Aged; Pyridines; Stroke; Thromboembolism; Treatment Outcome; Warfarin	2010
Risks for stroke, bleeding, and death in patients with atrial fibrillation receiving dabigatran or warfarin in relation to the CHADS2 score: a subgroup analysis of the RE-LY trial. Annals of internal medicine, 2011, Nov-15, Volume: 155, Issue:10 Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cause of Death; Dabigatran; Female; Hemorrhage; Humans; Male; Middle Aged; Risk Assessment; Risk Factors; Stroke; Thromboembolism; Warfarin	2011
Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial. Circulation, 2012, Jul-17, Volume: 126, Issue:3 Topics: Aged; Aged, 80 and over; Anticoagulants; Benzimidazoles; beta-Alanine; Blood Loss, Surgical; Brain Ischemia; Cardiac Pacing, Artificial; Cataract Extraction; Dabigatran; Female; Follow-Up Studies; Hemorrhage; Humans; Incidence; Male; Middle Aged; Postoperative Complications; Risk Factors; Stroke; Thromboembolism; Warfarin	2012
A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: THE Randomized, phase II study to evaluate the safety and pharmacokinetics of oral dabigatran etexilate in patients after heart valve replacement (RE-ALIGN). American heart journal, 2012, Volume: 163, Issue:6 Topics: Adolescent; Adult; Aged; Anticoagulants; Antithrombin Proteins; Benzimidazoles; Dabigatran; Dose-Response Relationship, Drug; Female; Heart Valve Prosthesis Implantation; Humans; International Normalized Ratio; Male; Middle Aged; Pyridines; Research Design; Thromboembolism; Warfarin; Young Adult	2012
Efficacy and safety of periprocedural dabigatran in patients undergoing catheter ablation of atrial fibrillation. Circulation journal : official journal of the Japanese Circulation Society, 2012, Volume: 76, Issue:10 Topics: Aged; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Catheter Ablation; Dabigatran; Female; Humans; Male; Middle Aged; Perioperative Care; Thromboembolism; Warfarin	2012
Dose escalating safety study of a new oral direct thrombin inhibitor, dabigatran etexilate, in patients undergoing total hip replacement: BISTRO I. Journal of thrombosis and haemostasis : JTH, 2004, Volume: 2, Issue:9 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Benzimidazoles; Dabigatran; Dose-Response Relationship, Drug; Female; Hemorrhage; Humans; Male; Middle Aged; Prodrugs; Pyridines; Safety; Thrombin; Thromboembolism; Venous Thrombosis	2004
A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial. Journal of thrombosis and haemostasis : JTH, 2005, Volume: 3, Issue:1 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles; Dabigatran; Dose-Response Relationship, Drug; Double-Blind Method; Enoxaparin; Female; Humans; Male; Middle Aged; Odds Ratio; Postoperative Complications; Postoperative Period; Pyridines; Regression Analysis; Thrombin; Thromboembolism	2005
Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial. Lancet (London, England), 2007, Sep-15, Volume: 370, Issue:9591 Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Benzimidazoles; Dabigatran; Double-Blind Method; Enoxaparin; Female; Hemorrhage; Humans; Male; Middle Aged; Postoperative Complications; Pyridines; Thromboembolism; Venous Thrombosis	2007
Dabigatran with or without concomitant aspirin compared with warfarin alone in patients with nonvalvular atrial fibrillation (PETRO Study). The American journal of cardiology, 2007, Nov-01, Volume: 100, Issue:9 Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Benzimidazoles; Dabigatran; Female; Fibrin Fibrinogen Degradation Products; Humans; International Normalized Ratio; Liver Function Tests; Male; Partial Thromboplastin Time; Platelet Aggregation Inhibitors; Pyridines; Thromboembolism; Warfarin	2007

Other Studies

177 other study(ies) available for dabigatran and Thromboembolism

Article	Year
Effectiveness and Safety of Dabigatran in Atrial Fibrillation Patients with Severe Obesity: a Real-World Retrospective Cohort Study. Journal of general internal medicine, 2022, Volume: 37, Issue:12 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Cohort Studies; Dabigatran; Gastrointestinal Hemorrhage; Humans; Obesity, Morbid; Retrospective Studies; Stroke; Thromboembolism; Treatment Outcome; Warfarin	2022
Adverse events in patients taking apixaban or rivaroxaban who have undergone bariatric surgery: a retrospective case series. Journal of thrombosis and thrombolysis, 2022, Volume: 53, Issue:3 Topics: Administration, Oral; Adult; Anticoagulants; Atrial Fibrillation; Bariatric Surgery; Dabigatran; Hemorrhage; Humans; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Thromboembolism; Thrombosis	2022
Dabigatran for stroke prevention in real life in a sample of population from Turkey: D-SPIRIT registry. Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir, 2021, Volume: 49, Issue:8 Topics: Age Factors; Aged; Antithrombins; Atrial Fibrillation; Cause of Death; Dabigatran; Diabetes Mellitus; Embolism; Female; Heart Failure; Hemorrhage; Humans; Hypertension; Ischemic Attack, Transient; Male; Myocardial Infarction; Product Surveillance, Postmarketing; Prospective Studies; Registries; Sex Factors; Stroke; Thromboembolism; Turkey	2021
Successful percutaneous extraction of malpositioned pacemaker lead in the left ventricle after proper dabigatran treatment. Pacing and clinical electrophysiology : PACE, 2022, Volume: 45, Issue:9 Topics: Dabigatran; Echocardiography; Heart Ventricles; Humans; Pacemaker, Artificial; Thromboembolism	2022
Nine-Year Trends in Prevention of Thromboembolic Complications in Elderly Patients with Atrial Fibrillation Treated with NOACs. International journal of environmental research and public health, 2022, 09-21, Volume: 19, Issue:19 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Dabigatran; Female; Hemorrhage; Humans; Hypertension; Male; Pyridones; Rivaroxaban; Stroke; Thromboembolism	2022
Efficacy and Safety of Direct Oral Anticoagulants in Patients With Atrial Fibrillation Combined With Hypertension: A Multicenter, Retrospective Cohort Study. Journal of clinical pharmacology, 2023, Volume: 63, Issue:8 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Hemorrhage; Humans; Hypertension; Retrospective Studies; Rivaroxaban; Stroke; Thromboembolism; Warfarin	2023
Effectiveness and safety of secondary prevention of non-vitamin K oral anticoagulants use by drug type in Asian patients. International journal of stroke : official journal of the International Stroke Society, 2023, Volume: 18, Issue:8 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Embolism; Hemorrhage; Humans; Ischemic Stroke; Retrospective Studies; Rivaroxaban; Secondary Prevention; Stroke; Thromboembolism; Vitamin K; Warfarin	2023
DOAC Dosing Discordance Using Different Estimates of Kidney Function and Outcomes. Journal of clinical pharmacology, 2023, Volume: 63, Issue:9 Topics: Administration, Oral; Adult; Anticoagulants; Atrial Fibrillation; Dabigatran; Humans; Kidney; Pyridones; Renal Insufficiency, Chronic; Retrospective Studies; Rivaroxaban; Stroke; Thromboembolism	2023
Effectiveness and Safety of Dabigatran Reversal with Idarucizumab in the Taiwanese Population: A Comparison Based on Eligibility for Inclusion in Clinical Trials. Medicina (Kaunas, Lithuania), 2023, May-04, Volume: 59, Issue:5 Topics: Antithrombins; Blood Coagulation; Dabigatran; Hemorrhage; Humans; Ischemic Stroke; Retrospective Studies; Thromboembolism	2023
Baseline Characteristics and 3-Year Outcome of Nonvalvular Atrial Fibrillation Patients Treated with the Four Direct Oral Anticoagulants (DOACs). The American journal of cardiology, 2023, 11-01, Volume: 206 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Female; Hemorrhage; Humans; Male; Pyridones; Retrospective Studies; Rivaroxaban; Stroke; Thromboembolism	2023
Anticoagulation and cataract surgery. The New Zealand medical journal, 2019, 08-16, Volume: 132, Issue:1500 Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Dabigatran; Female; Humans; Male; Middle Aged; Phacoemulsification; Postoperative Complications; Postoperative Hemorrhage; Retrospective Studies; Thromboembolism; Warfarin	2019
[Effectiveness, safety and costs of stroke prevention in non-valvular auricular fibrillation. Study of cohorts matched by Propensity score]. Atencion primaria, 2020, Volume: 52, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Cohort Studies; Costs and Cost Analysis; Dabigatran; Female; Hemorrhage; Hospitalization; Humans; Incidence; Male; Middle Aged; Primary Health Care; Propensity Score; Stroke; Thromboembolism; Vitamin K	2020
Safety of cataract surgery in patients treated with the new oral anticoagulants (NOACs). Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2019, Volume: 257, Issue:12 Topics: Administration, Oral; Aged; Aged, 80 and over; Antithrombins; Blood Loss, Surgical; Dabigatran; Eye Hemorrhage; Factor Xa Inhibitors; Female; Follow-Up Studies; Humans; Incidence; Israel; Male; Middle Aged; Phacoemulsification; Postoperative Hemorrhage; Prospective Studies; Pyrazoles; Pyridones; Rivaroxaban; Thromboembolism	2019
A national audit on the utilisation and documentation of dabigatran checklist for patients initiated on dabigatran. The Medical journal of Malaysia, 2019, Volume: 74, Issue:5 Topics: Administration, Oral; Aged; Antithrombins; Checklist; Dabigatran; Drug Prescriptions; Drug Utilization; Female; Humans; Malaysia; Male; Medical Audit; Retrospective Studies; Thromboembolism	2019
Comparison of the Effect of Age (< 75 Versus ≥ 75) on the Efficacy and Safety of Dual Therapy (Dabigatran + Clopidogrel or Ticagrelor) Versus Triple Therapy (Warfarin + Aspirin + Clopidogrel or Ticagrelor) in Patients With Atrial Fibrillation After Percut The American journal of cardiology, 2020, 03-01, Volume: 125, Issue:5 Topics: Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Dabigatran; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Revascularization; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Proportional Hazards Models; Stroke; Thromboembolism; Ticagrelor; Treatment Outcome; Warfarin	2020
[Pharmaco-utilization and outcomes in patients treated with oral anticoagulants from 2014 to 2015: evidences from administrative databases of the Romagna Local Health Unit]. Giornale italiano di cardiologia (2006), 2020, Volume: 21, Issue:1 Topics: Administration, Oral; Aged; Anticoagulants; Antithrombins; Atrial Fibrillation; Cause of Death; Comorbidity; Dabigatran; Databases, Factual; Female; Hemorrhage; Humans; Male; Medication Adherence; Platelet Aggregation Inhibitors; Propensity Score; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Stroke; Thromboembolism; Warfarin	2020
Characteristics and outcomes in patients with atrial fibrillation receiving direct oral anticoagulants in off-label doses. BMC cardiovascular disorders, 2020, 02-03, Volume: 20, Issue:1 Topics: Administration, Oral; Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Dabigatran; Databases, Factual; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Medicare; Off-Label Use; Practice Patterns, Physicians'; Retrospective Studies; Risk Assessment; Risk Factors; Rivaroxaban; Stroke; Thromboembolism; Time Factors; Treatment Outcome; United States	2020
Blood Coagulation Status during Cryofreezing Ablation and Effects of the Direct Anticoagulants Dabigatran and Edoxaban. International heart journal, 2020, Mar-28, Volume: 61, Issue:2 Topics: Aged; Antithrombins; Cryosurgery; Dabigatran; Female; Humans; Male; Middle Aged; Pyridines; Thiazoles; Thromboembolism	2020
Assessment of direct oral anticoagulants administered as potentially inappropriate medications to elderly inpatients. International journal of clinical pharmacy, 2020, Volume: 42, Issue:3 Topics: Age Factors; Aged; Aged, 80 and over; Anticoagulants; China; Creatinine; Cross-Sectional Studies; Dabigatran; Hemorrhage; Humans; Inappropriate Prescribing; Inpatients; Length of Stay; Male; Polypharmacy; Retrospective Studies; Risk Factors; Rivaroxaban; Thromboembolism	2020
Does the CHA2DS2-VASc scale sufficiently predict the risk of left atrial appendage thrombus in patients with diagnosed atrial fibrillation treated with non-vitamin K oral anticoagulants? Medicine, 2020, Jun-19, Volume: 99, Issue:25 Topics: Aged; Atrial Appendage; Atrial Fibrillation; Dabigatran; Echocardiography, Transesophageal; Factor Xa Inhibitors; Female; Humans; Male; Middle Aged; Pyrazoles; Pyridones; Risk Assessment; Risk Factors; Rivaroxaban; Thromboembolism	2020
Comparison of the Efficacy and Safety of Direct Oral Anticoagulants and Warfarin After Bioprosthetic Valve Replacements. Clinical drug investigation, 2020, Volume: 40, Issue:9 Topics: Administration, Oral; Aged; Anticoagulants; Bioprosthesis; Dabigatran; Female; Heart Valve Prosthesis; Hemorrhage; Humans; Male; Middle Aged; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Thromboembolism; Warfarin	2020
Influence of anticoagulants on the risk of delayed bleeding after gastric endoscopic submucosal dissection: a multicenter retrospective study. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2021, Volume: 24, Issue:1 Topics: Aged; Aged, 80 and over; Anticoagulants; Dabigatran; Endoscopic Mucosal Resection; Female; Humans; Japan; Male; Middle Aged; Postoperative Complications; Postoperative Hemorrhage; Pyrazoles; Pyridines; Pyridones; Retrospective Studies; Rivaroxaban; Stomach; Stomach Neoplasms; Thiazoles; Thromboembolism; Warfarin	2021
A Survey of Direct Oral Anticoagulant Cessation in General Surgery and Outcomes in Patients with Nonvalvular Atrial Fibrillation. International heart journal, 2020, Sep-29, Volume: 61, Issue:5 Topics: Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Blood Loss, Surgical; Carotid Artery Diseases; Cerebral Infarction; Dabigatran; Digestive System Surgical Procedures; Elective Surgical Procedures; Embolism; Endoscopy; Factor Xa Inhibitors; Female; Humans; Male; Myocardial Infarction; Orthopedic Procedures; Perioperative Care; Postoperative Complications; Postoperative Hemorrhage; Pyrazoles; Pyridines; Pyridones; Retrospective Studies; Rivaroxaban; Thiazoles; Thromboembolism; Urologic Surgical Procedures; Vascular Surgical Procedures	2020
Risks of post-colonoscopic polypectomy bleeding and thromboembolism with warfarin and direct oral anticoagulants: a population-based analysis. Gut, 2022, Volume: 71, Issue:1 Topics: Aged; Anticoagulants; Blood Transfusion; Cohort Studies; Colonic Polyps; Colonoscopy; Dabigatran; Factor Xa Inhibitors; Gastrointestinal Hemorrhage; Hong Kong; Humans; Male; Postoperative Complications; Pyrazoles; Pyridones; Retrospective Studies; Risk Assessment; Rivaroxaban; Thromboembolism; Warfarin	2022
[Is one DOAC better than another?] Nederlands tijdschrift voor geneeskunde, 2021, 04-26, Volume: 164 Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Dabigatran; Drug Administration Schedule; Female; Hemorrhage; Humans; Male; Pyrazoles; Pyridones; Rivaroxaban; Thromboembolism; Treatment Outcome	2021
Risk of major bleeding and thromboembolism in Asian patients with nonvalvular atrial fibrillation using direct oral anticoagulants versus warfarin. International journal of clinical pharmacy, 2022, Volume: 44, Issue:1 Topics: Administration, Oral; Anticoagulants; Asian People; Atrial Fibrillation; Cohort Studies; Dabigatran; Hemorrhage; Humans; Retrospective Studies; Rivaroxaban; Stroke; Thromboembolism; Warfarin	2022
Predictors of Direct Oral Anticoagulants Utilization for Thromboembolism Prevention in Atrial Fibrillation. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 2017, Volume: 20 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Cross-Sectional Studies; Dabigatran; Female; Humans; Male; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Thromboembolism; Warfarin	2017
Safety and efficacy of DOACs vs acenocoumarol in patients undergoing catheter ablation of atrial fibrillation. Clinical cardiology, 2017, Volume: 40, Issue:10 Topics: Acenocoumarol; Administration, Oral; Aged; Anticoagulants; Antithrombins; Atrial Fibrillation; Catheter Ablation; Dabigatran; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Middle Aged; Prospective Studies; Pyrazoles; Pyridones; Registries; Risk Factors; Rivaroxaban; Thromboembolism; Time Factors; Treatment Outcome	2017
Thrombocytopenia induced by dabigatran: two case reports. BMC neurology, 2017, Jun-29, Volume: 17, Issue:1 Topics: Aged; Antithrombins; Dabigatran; Female; Hemorrhage; Humans; Male; Thrombocytopenia; Thromboembolism; Warfarin	2017
Replacing warfarin therapy with the newer direct oral anticoagulants, or simply a growth in anticoagulation therapy? Implications for pathology testing. Pathology, 2017, Volume: 49, Issue:6 Topics: Administration, Oral; Anticoagulants; Dabigatran; Humans; Prescriptions; Pyrazoles; Pyridones; Rivaroxaban; Thromboembolism; Warfarin	2017
The cost-effectiveness and monetary benefits of dabigatran in the prevention of arterial thromboembolism for patients with non-valvular atrial fibrillation in the Netherlands. Journal of medical economics, 2018, Volume: 21, Issue:1 Topics: Antithrombins; Atrial Fibrillation; Cohort Studies; Cost-Benefit Analysis; Dabigatran; Female; Humans; Male; Markov Chains; Netherlands; Quality-Adjusted Life Years; Retrospective Studies; Risk Assessment; Thromboembolism; Treatment Outcome; Vitamin K	2018
Uninterrupted dabigatran for ablation in atrial fibrillation: Peering into the black box of intra-procedural anticoagulation. Anaesthesia, critical care & pain medicine, 2018, Volume: 37, Issue:4 Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Catheter Ablation; Dabigatran; Guidelines as Topic; Humans; Intraoperative Care; Thromboembolism	2018
Comparison of different oral anticoagulant regimens in patients with atrial fibrillation undergoing ablation or cardioversion. Polish archives of internal medicine, 2017, 12-22, Volume: 127, Issue:12 Topics: Administration, Oral; Aged; Antithrombins; Atrial Fibrillation; Dabigatran; Female; Humans; Incidence; Male; Middle Aged; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thromboembolism	2017
Oral anticoagulant persistence in patients with non-valvular atrial fibrillation: A cohort study using primary care data in Germany. PloS one, 2017, Volume: 12, Issue:10 Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Cohort Studies; Dabigatran; Female; Germany; Hemorrhage; Humans; Hypertension; Ischemic Attack, Transient; Male; Primary Health Care; Pyrazoles; Pyridones; Risk Factors; Rivaroxaban; Stroke; Thromboembolism; Vitamin K	2017
Letter by Heinrich-Nols and Kreuzer Regarding Article, "Increased Thromboembolic Events With Dabigatran Compared With Vitamin K Antagonism in Left Ventricular Assist Device Patients: A Randomized Controlled Pilot Trial". Circulation. Heart failure, 2017, Volume: 10, Issue:10 Topics: Anticoagulants; Dabigatran; Heart-Assist Devices; Humans; Pilot Projects; Thromboembolism; Vitamin K	2017
Response by Andreas et al to Letter Regarding Article, "Increased Thromboembolic Events With Dabigatran Compared With Vitamin K Antagonism in Left Ventricular Assist Device Patients: A Randomized Controlled Pilot Trial". Circulation. Heart failure, 2017, Volume: 10, Issue:10 Topics: Anticoagulants; Dabigatran; Heart-Assist Devices; Humans; Pilot Projects; Thromboembolism; Vitamin K	2017
Inappropriate doses of direct oral anticoagulants in real-world clinical practice: prevalence and associated factors. A subanalysis of the FANTASIIA Registry. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2018, 10-01, Volume: 20, Issue:10 Topics: Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Comorbidity; Dabigatran; Factor Xa Inhibitors; Female; Guideline Adherence; Humans; Inappropriate Prescribing; Logistic Models; Male; Middle Aged; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Registries; Retrospective Studies; Rivaroxaban; Stroke; Thromboembolism	2018
Optimal dose of dabigatran for the prevention of thromboembolism with minimal bleeding risk in Korean patients with atrial fibrillation. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2017, Dec-01, Volume: 19, Issue:suppl_4 Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Blood Coagulation; Chi-Square Distribution; Dabigatran; Female; Hemorrhage; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Propensity Score; Proportional Hazards Models; Republic of Korea; Retrospective Studies; Risk Assessment; Risk Factors; Stroke; Thromboembolism; Time Factors; Treatment Outcome; Warfarin	2017
Association of Novel Oral Antithrombotics With the Risk of Intraocular Bleeding. JAMA ophthalmology, 2018, 02-01, Volume: 136, Issue:2 Topics: Administration, Oral; Aged; Anticoagulants; Antithrombins; Dabigatran; Dose-Response Relationship, Drug; Eye Hemorrhage; Factor Xa Inhibitors; Female; Follow-Up Studies; Humans; Incidence; Male; Pennsylvania; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors; Rivaroxaban; Thromboembolism; Warfarin	2018
Efficacy and safety of dabigatran in patients with atrial fibrillation scheduled for transoesophageal echocardiogram-guided direct electrical current cardioversion: a prospective propensity score-matched cohort study. Journal of thrombosis and thrombolysis, 2018, Volume: 45, Issue:2 Topics: Adult; Aged; Atrial Fibrillation; Cohort Studies; Dabigatran; Echocardiography, Transesophageal; Electric Countershock; Female; Follow-Up Studies; Hemorrhage; Humans; Male; Middle Aged; Propensity Score; Prospective Studies; Thromboembolism; Treatment Outcome; Vitamin K	2018
Treatment failure of direct oral anticoagulants in anti-phospholipid syndrome. Scandinavian journal of rheumatology, 2018, Volume: 47, Issue:5 Topics: Administration, Oral; Anticoagulants; Antiphospholipid Syndrome; Dabigatran; Female; Humans; Male; Middle Aged; Thromboembolism; Treatment Failure	2018
Is There a Preferred Stroke Prevention Strategy for Diabetic Patients with Non-Valvular Atrial Fibrillation? Comparing Warfarin, Dabigatran and Rivaroxaban. Thrombosis and haemostasis, 2018, Volume: 118, Issue:1 Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Cohort Studies; Comparative Effectiveness Research; Dabigatran; Databases, Factual; Diabetes Complications; Diabetes Mellitus; Female; Humans; Male; Middle Aged; Patient Safety; Proportional Hazards Models; Risk; Risk Factors; Rivaroxaban; Stroke; Taiwan; Thromboembolism; Treatment Outcome; Warfarin	2018
Generalized boosted modeling to identify subgroups where effect of dabigatran versus warfarin may differ: An observational cohort study of patients with atrial fibrillation. Pharmacoepidemiology and drug safety, 2018, Volume: 27, Issue:4 Topics: Aged; Anticoagulants; Atrial Fibrillation; Cohort Studies; Dabigatran; Female; Humans; Male; Middle Aged; Models, Biological; Primary Prevention; Recurrence; Secondary Prevention; Stroke; Thromboembolism; Treatment Outcome; Warfarin	2018
Low drug levels and thrombotic complications in high-risk atrial fibrillation patients treated with direct oral anticoagulants. Journal of thrombosis and haemostasis : JTH, 2018, Volume: 16, Issue:5 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Blood Coagulation Tests; Dabigatran; Drug Monitoring; Factor Xa Inhibitors; Female; Humans; Male; Middle Aged; Predictive Value of Tests; Preliminary Data; Pyrazoles; Pyridones; Registries; Risk Assessment; Risk Factors; Rivaroxaban; Thromboembolism; Time Factors; Treatment Outcome	2018
District versus academic hospitals: differences in the clinical characteristics of patients with atrial fibrillation without valvular heart disease treated with oral anticoagulants Polish archives of internal medicine, 2018, 03-17, Volume: 128, Issue:5 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Dabigatran; Female; Heart Valve Diseases; Hospitals, District; Hospitals, University; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Rivaroxaban; Stroke; Thromboembolism	2018
Secondary adherence to non-vitamin-K antagonist oral anticoagulants in patients with atrial fibrillation in Sweden and the Netherlands. Current medical research and opinion, 2018, Volume: 34, Issue:10 Topics: Administration, Oral; Aged; Antithrombins; Atrial Fibrillation; Dabigatran; Dose-Response Relationship, Drug; Drug Utilization Review; Female; Humans; Male; Medication Adherence; Middle Aged; Netherlands; Pyrazoles; Pyridones; Rivaroxaban; Sweden; Thromboembolism	2018
Efficacy and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Asians With Nonvalvular Atrial Fibrillation. Journal of the American Heart Association, 2018, 04-05, Volume: 7, Issue:8 Topics: Aged; Anticoagulants; Antithrombins; Atrial Fibrillation; Dabigatran; Dose-Response Relationship, Drug; Drug Therapy, Combination; Factor Xa Inhibitors; Female; Humans; Incidence; Male; Propensity Score; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Taiwan; Thromboembolism; Treatment Outcome; Warfarin	2018
Safety and Efficacy of Novel Oral Anticoagulants Versus Warfarin in Medicare Beneficiaries With Atrial Fibrillation and Valvular Heart Disease. Journal of the American Heart Association, 2018, 04-05, Volume: 7, Issue:8 Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Dabigatran; Dose-Response Relationship, Drug; Factor Xa Inhibitors; Female; Follow-Up Studies; Heart Valve Diseases; Humans; Male; Medicare; Retrospective Studies; Rivaroxaban; Thromboembolism; Treatment Outcome; United States; Warfarin	2018
Assessment of patients post reversal with idarucizumab. Journal of thrombosis and thrombolysis, 2018, Volume: 46, Issue:4 Topics: Adult; Antibodies, Monoclonal, Humanized; Antithrombins; Blood Coagulation; Dabigatran; Drug Interactions; Hemorrhage; Hemostasis; Humans; Thromboembolism; Thrombosis; Time Factors; Treatment Outcome	2018
The Comparison of Inappropriate-Low-Doses Use among 4 Direct Oral Anticoagulants in Patients with Atrial Fibrillation: From the Database of a Single-Center Registry. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2018, Volume: 27, Issue:11 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Blood Coagulation; Chi-Square Distribution; Dabigatran; Databases, Factual; Drug Dosage Calculations; Female; Hemorrhage; Humans; Inappropriate Prescribing; Incidence; Japan; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Odds Ratio; Prevalence; Pyrazoles; Pyridines; Pyridones; Registries; Retrospective Studies; Risk Factors; Rivaroxaban; Stroke; Thiazoles; Thromboembolism; Time Factors; Treatment Outcome	2018
Long-term outcome in patients with non-valvular atrial fibrillation on dabigatran: a prospective cohort study. Expert opinion on drug safety, 2018, Volume: 17, Issue:11 Topics: Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Cohort Studies; Dabigatran; Female; Follow-Up Studies; Hemorrhage; Humans; Italy; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Stroke; Thromboembolism; Treatment Outcome	2018
Performance of idarucizumab as antidote of dabigatran in daily clinical practice. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2019, Mar-01, Volume: 21, Issue:3 Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antidotes; Antithrombins; Clinical Decision-Making; Dabigatran; Female; Hemorrhage; Hemostasis; Humans; Male; Netherlands; Patient Selection; Recurrence; Retrospective Studies; Risk Assessment; Risk Factors; Thromboembolism; Time Factors; Treatment Outcome	2019
Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients With Impaired Liver Function: A Retrospective Cohort Study. Journal of the American Heart Association, 2018, 08-07, Volume: 7, Issue:15 Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Cohort Studies; Dabigatran; Factor Xa Inhibitors; Female; Gastrointestinal Hemorrhage; Hemorrhage; Hepatic Insufficiency; Humans; Male; Proportional Hazards Models; Pyrazoles; Pyridines; Pyridones; Retrospective Studies; Rivaroxaban; Stroke; Thiazoles; Thromboembolism; Warfarin	2018
Limitations of Specific Coagulation Tests for Direct Oral Anticoagulants: A Critical Analysis. Journal of the American Heart Association, 2018, 10-02, Volume: 7, Issue:19 Topics: Administration, Oral; Aged; Antithrombins; Blood Coagulation; Blood Coagulation Tests; Dabigatran; Dose-Response Relationship, Drug; Factor Xa Inhibitors; Female; Follow-Up Studies; Humans; Male; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Thromboembolism; Thrombolytic Therapy	2018
A novel protocol for initial heparin administration during catheter ablation for atrial fibrillation in patients taking direct oral anticoagulants. Heart and vessels, 2019, Volume: 34, Issue:5 Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Blood Coagulation; Catheter Ablation; Dabigatran; Female; Heparin; Humans; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; ROC Curve; Thromboembolism; Time Factors	2019
Dabigatran Versus Rivaroxaban for Secondary Stroke Prevention in Patients with Atrial Fibrillation Rehabilitated in Skilled Nursing Facilities. Drugs & aging, 2018, Volume: 35, Issue:12 Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Cohort Studies; Dabigatran; Female; Hemorrhage; Humans; Intracranial Hemorrhages; Ischemic Attack, Transient; Male; Medicare; Myocardial Infarction; Proportional Hazards Models; Retrospective Studies; Rivaroxaban; Secondary Prevention; Skilled Nursing Facilities; Stroke; Thromboembolism; United States	2018
Orthotopic liver transplantation in a patient receiving apixaban for portal vein thrombosis. Journal of clinical anesthesia, 2019, Volume: 56 Topics: Aged; Blood Loss, Surgical; Carcinoma, Hepatocellular; Dabigatran; Humans; Infusions, Intravenous; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Mesenteric Vascular Occlusion; Mesenteric Veins; Pyrazoles; Pyridones; Risk Assessment; Thromboembolism; Tranexamic Acid; Venous Thrombosis	2019
Effectiveness and safety of long-term dabigatran among patients with non-valvular atrial fibrillation in clinical practice: J-dabigatran surveillance. Journal of cardiology, 2019, Volume: 73, Issue:6 Topics: Aged; Antithrombins; Atrial Fibrillation; Dabigatran; Drug Monitoring; Embolism; Female; Hemorrhage; Humans; Male; Middle Aged; Risk Assessment; Stroke; Thromboembolism; Time Factors; Treatment Outcome	2019
Diagnostic and therapeutic approach in adult patients with traumatic brain injury receiving oral anticoagulant therapy: an Austrian interdisciplinary consensus statement. Critical care (London, England), 2019, Feb-22, Volume: 23, Issue:1 Topics: Administration, Oral; Anticoagulants; Austria; Brain Injuries, Traumatic; Consensus; Dabigatran; Deamino Arginine Vasopressin; Humans; Interdisciplinary Communication; Partial Thromboplastin Time; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thromboembolism; Tomography, X-Ray Computed; Tranexamic Acid; Treatment Outcome; Vitamin K	2019
Dabigatran and warfarin in nonvalvular atrial fibrillation or atrial flutter in outpatient clinic practice in Brazil. Arquivos de neuro-psiquiatria, 2019, Volume: 77, Issue:2 Topics: Aged; Aged, 80 and over; Ambulatory Care Facilities; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Atrial Flutter; Brazil; Dabigatran; Female; Follow-Up Studies; Hemorrhage; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Statistics, Nonparametric; Stroke; Thromboembolism; Treatment Outcome; Warfarin	2019
Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulant and Warfarin in Cirrhotic Patients With Nonvalvular Atrial Fibrillation. Journal of the American Heart Association, 2019, 03-05, Volume: 8, Issue:5 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Dabigatran; Female; Hemorrhage; Humans; Liver Cirrhosis; Male; Middle Aged; Patient Safety; Pyrazoles; Pyridones; Retrospective Studies; Risk Assessment; Risk Factors; Rivaroxaban; Stroke; Taiwan; Thromboembolism; Time Factors; Treatment Outcome; Warfarin	2019
Safety and Efficacy of Triple Antithrombotic Therapy with Dabigatran versus Vitamin K Antagonist in Atrial Fibrillation Patients: A Pilot Study. BioMed research international, 2019, Volume: 2019 Topics: Aged; Atrial Fibrillation; Dabigatran; Drug Therapy, Combination; Female; Fibrinolytic Agents; Hemorrhage; Hospitalization; Humans; Kaplan-Meier Estimate; Male; Medication Adherence; Pilot Projects; Probability; Propensity Score; Thromboembolism; Treatment Outcome; Vitamin K	2019
Deprivation and inequalities lead to worse outcomes with dabigatran etexilate. Journal of primary health care, 2018, Volume: 10, Issue:4 Topics: Aged; Aged, 80 and over; Anticoagulants; Dabigatran; Female; Hemorrhage; Hospitalization; Humans; Male; Middle Aged; Native Hawaiian or Other Pacific Islander; New Zealand; Proportional Hazards Models; Retrospective Studies; Risk Factors; Socioeconomic Factors; Statistics, Nonparametric; Stroke; Thromboembolism; Treatment Outcome; White People	2018
Effectiveness and Safety of Four Direct Oral Anticoagulants in Asian Patients With Nonvalvular Atrial Fibrillation. Chest, 2019, Volume: 156, Issue:3 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Asian People; Atrial Fibrillation; Dabigatran; Databases, Factual; Female; Hemorrhage; Humans; Male; Middle Aged; Pyrazoles; Pyridines; Pyridones; Retrospective Studies; Rivaroxaban; Stroke; Taiwan; Thiazoles; Thromboembolism; Treatment Outcome; Warfarin	2019
Excessive Prolongation of Coagulation Time During Treatment With Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation. The Canadian journal of cardiology, 2019, Volume: 35, Issue:6 Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Blood Coagulation; Blood Coagulation Tests; Dabigatran; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Incidence; Japan; Male; Prognosis; Pyridines; Retrospective Studies; Thiazoles; Thromboembolism	2019
RE-CIRCUIT: uninterrupted anticoagulation with dabigatran to cover left atrial ablation procedures. Cardiovascular research, 2018, 10-01, Volume: 114, Issue:12 Topics: Ablation Techniques; Administration, Oral; Antithrombins; Atrial Fibrillation; Dabigatran; Drug Administration Schedule; Hemorrhage; Humans; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Stroke; Thromboembolism; Treatment Outcome	2018
[Extensive thromboembolism after cardioversion in a patient treated with dabigatran]. Ugeskrift for laeger, 2013, Feb-04, Volume: 175, Issue:6 Topics: Aged; Antithrombins; Benzimidazoles; beta-Alanine; Cerebral Infarction; Dabigatran; Electric Countershock; Humans; Ileus; Kidney Diseases; Male; Risk Factors; Thromboembolism; Tomography, X-Ray Computed; Vitamin K	2013
Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation. Circulation. Arrhythmia and electrophysiology, 2013, Volume: 6, Issue:3 Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Confidence Intervals; Dabigatran; Dose-Response Relationship, Drug; Drug Administration Schedule; Electrocardiography; Female; Follow-Up Studies; Humans; Intraoperative Care; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Perioperative Care; Postoperative Complications; Prospective Studies; Registries; Risk Assessment; Severity of Illness Index; Survival Rate; Thromboembolism; Thrombolytic Therapy; Treatment Outcome; Warfarin	2013
[Your patient needs antithrombotics, 2. What do the new substances offer? (interview by Dr. med. Peter Stiefelhagen)]. MMW Fortschritte der Medizin, 2013, Feb-21, Volume: 155, Issue:3 Topics: Adenosine; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cardiovascular Diseases; Clopidogrel; Dabigatran; Fibrinolytic Agents; Guideline Adherence; Humans; Morpholines; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Thromboembolism; Ticagrelor; Ticlopidine; Treatment Outcome	2013
Dabigatran in the peri-procedural period for radiofrequency ablation of atrial fibrillation: efficacy, safety, and impact on duration of hospital stay. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2013, Volume: 37, Issue:3 Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Catheter Ablation; Comorbidity; Dabigatran; Decision Making; Drug-Related Side Effects and Adverse Reactions; Evidence-Based Medicine; Female; Humans; Japan; Length of Stay; Male; Middle Aged; Premedication; Risk Factors; Thromboembolism; Treatment Outcome	2013
New approaches to reversing oral anticoagulant therapy. Introduction. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2013, May-15, Volume: 70, Issue:10 Suppl 1 Topics: Administration, Oral; Anticoagulants; Antifibrinolytic Agents; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Hemorrhage; Humans; Morpholines; Plasma; Primary Prevention; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Thromboembolism; Treatment Outcome; Vitamin K 1	2013
Pharmacologic interventions for reversing the effects of oral anticoagulants. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2013, May-15, Volume: 70, Issue:10 Suppl 1 Topics: Administration, Oral; Anticoagulants; Antifibrinolytic Agents; Antithrombins; Benzimidazoles; beta-Alanine; Blood Coagulation Factors; Blood Loss, Surgical; Dabigatran; Drug Therapy, Combination; Emergencies; Hemorrhage; Humans; International Normalized Ratio; Morpholines; Plasma; Pyrazoles; Pyridones; Rivaroxaban; Surgical Procedures, Operative; Thiophenes; Thromboembolism; Treatment Outcome; Vitamin K 1; Warfarin	2013
Perioperative management of patients who are receiving a novel oral anticoagulant. Internal and emergency medicine, 2013, Volume: 8, Issue:6 Topics: Aged; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Male; Morpholines; Perioperative Care; Postoperative Complications; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban; Thiophenes; Thromboembolism	2013
Fatal association of mechanical valve thrombosis with dabigatran: a report of two cases. Chest, 2013, Volume: 144, Issue:1 Topics: Aged; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Fatal Outcome; Female; Heart Valve Prosthesis; Humans; Mitral Valve; Thromboembolism	2013
Periprocedural dabigatran anticoagulation for atrial fibrillation ablation: do we have enough information to make a rational decision. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2013, Volume: 37, Issue:3 Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Catheter Ablation; Comorbidity; Dabigatran; Decision Making; Drug-Related Side Effects and Adverse Reactions; Evidence-Based Medicine; Humans; Premedication; Risk Factors; Thromboembolism; Treatment Outcome	2013
Dabigatran and mechanical heart valves--not as easy as we hoped. The New England journal of medicine, 2013, Sep-26, Volume: 369, Issue:13 Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Female; Heart Valve Prosthesis; Humans; Male; Stroke; Thromboembolism; Warfarin	2013
Dabigatran in the setting of catheter ablation of atrial fibrillation: the road ahead. Heart (British Cardiac Society), 2014, Volume: 100, Issue:4 Topics: Atrial Fibrillation; Benzimidazoles; beta-Alanine; Catheter Ablation; Dabigatran; Humans; Preoperative Care; Thromboembolism; Warfarin	2014
Dabigatran etexilate for thromboembolic prophylaxis in non-valvular atrial fibrillation: the RE-LY study and substudies with commentary. Expert review of cardiovascular therapy, 2013, Volume: 11, Issue:11 Topics: Administration, Oral; Aged; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; Clinical Trials, Phase III as Topic; Dabigatran; Dose-Response Relationship, Drug; Female; Half-Life; Hemorrhage; Humans; Kidney Diseases; Male; Pyridines; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Thromboembolism; Warfarin	2013
Thromboembolism in a patient with a mechanical mitral valve during anticoagulation with dabigatran etexilate. The Annals of thoracic surgery, 2013, Volume: 96, Issue:5 Topics: Anticoagulants; Antithrombin Proteins; Benzimidazoles; Dabigatran; Heart Valve Prosthesis; Humans; Male; Middle Aged; Mitral Valve; Prosthesis Design; Pyridines; Thromboembolism	2013
Patient outcomes using the European label for dabigatran. A post-hoc analysis from the RE-LY database. Thrombosis and haemostasis, 2014, May-05, Volume: 111, Issue:5 Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cost-Benefit Analysis; Dabigatran; Databases, Factual; Europe; Female; Hemorrhage; Humans; Male; Middle Aged; Practice Guidelines as Topic; Stroke; Survival Analysis; Thromboembolism; Treatment Outcome; Warfarin	2014
Dabigatran in the setting of catheter ablation of atrial fibrillation: the road ahead. The authors' reply. Heart (British Cardiac Society), 2014, Volume: 100, Issue:4 Topics: Atrial Fibrillation; Benzimidazoles; beta-Alanine; Catheter Ablation; Dabigatran; Humans; Preoperative Care; Thromboembolism; Warfarin	2014
Treatment with novel oral anticoagulants in a real-world cohort of patients undergoing cardiac rhythm device implantations. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2014, Volume: 16, Issue:7 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cardiac Pacing, Artificial; Dabigatran; Defibrillators, Implantable; Electric Countershock; Female; Germany; Hematoma; Hemorrhage; Humans; Incidence; Male; Middle Aged; Morpholines; Pacemaker, Artificial; Prospective Studies; Prosthesis Design; Prosthesis Implantation; Risk Factors; Rivaroxaban; Thiophenes; Thromboembolism; Time Factors; Treatment Outcome	2014
[Extrapolation of physiopathological data to clinical practice: Example of dabigatran in off-label use]. Presse medicale (Paris, France : 1983), 2014, Volume: 43, Issue:4 Pt 1 Topics: Administration, Oral; Aged; Antithrombins; Benzimidazoles; beta-Alanine; Contraindications; Dabigatran; Drug Substitution; Early Termination of Clinical Trials; Female; Heart Valve Prosthesis Implantation; Hemorrhage; Humans; Male; Middle Aged; Mitral Valve; Myocardial Infarction; Off-Label Use; Postoperative Complications; Pyridines; Randomized Controlled Trials as Topic; Stroke; Thromboembolism; Vitamin K	2014
Rivaroxaban and dabigatran in patients undergoing catheter ablation of atrial fibrillation. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2014, Volume: 16, Issue:8 Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Catheter Ablation; Dabigatran; Drug Prescriptions; Drug Utilization Review; Female; Hemorrhage; Humans; Male; Middle Aged; Morpholines; Portugal; Practice Patterns, Physicians'; Prospective Studies; Risk Assessment; Risk Factors; Rivaroxaban; Thiophenes; Thromboembolism; Time Factors; Treatment Outcome	2014
Only high levels of dabigatran attenuate catheter thrombosis in vitro and in rabbits. Thrombosis and haemostasis, 2014, Jul-03, Volume: 112, Issue:1 Topics: Animals; Antithrombins; Benzimidazoles; beta-Alanine; Catheter Obstruction; Catheters; Dabigatran; Drug Dosage Calculations; Heart Valve Prosthesis Implantation; Heparin; Humans; In Vitro Techniques; Male; Models, Animal; Postoperative Complications; Rabbits; Thrombin; Thromboembolism; Thrombosis	2014
Safety of short-term use of dabigatran or rivaroxaban for direct-current cardioversion in patients with atrial fibrillation and atrial flutter. The American journal of cardiology, 2014, Apr-15, Volume: 113, Issue:8 Topics: Administration, Oral; Aged; Anticoagulants; Antithrombins; Atrial Fibrillation; Atrial Flutter; Benzimidazoles; beta-Alanine; Dabigatran; Dose-Response Relationship, Drug; Echocardiography, Transesophageal; Electric Countershock; Electrocardiography; Factor Xa Inhibitors; Female; Follow-Up Studies; Humans; Male; Morpholines; Retrospective Studies; Rivaroxaban; Thiophenes; Thromboembolism; Time Factors; Treatment Outcome	2014
Safety of new oral anticoagulants for patients undergoing atrial fibrillation ablation. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2014, Volume: 40, Issue:1 Topics: Aged; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Catheter Ablation; Dabigatran; Factor Xa Inhibitors; Female; Humans; Male; Middle Aged; Morpholines; Pulmonary Veins; Retrospective Studies; Rivaroxaban; Thiophenes; Thromboembolism; Warfarin	2014
Lessons from the RE-ALIGN trial. Archives of cardiovascular diseases, 2014, Volume: 107, Issue:5 Topics: Aged; Anticoagulants; Benzimidazoles; Bioprosthesis; Clinical Trials, Phase II as Topic; Dabigatran; Heart Valve Prosthesis; Hemorrhage; Humans; Myocardial Infarction; Postoperative Complications; Pyridines; Randomized Controlled Trials as Topic; Risk; Stroke; Thromboembolism; Warfarin	2014
Direct oral anticoagulants--pharmacology, drug interactions, and side effects. Seminars in hematology, 2014, Volume: 51, Issue:2 Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Drug Interactions; Drug Monitoring; Half-Life; Hemorrhage; Humans; Kidney; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thiophenes; Thromboembolism	2014
Myocardial infarction complicated by left ventricular thrombus and fatal thromboembolism following abrupt cessation of dabigatran. BMJ case reports, 2014, Jul-04, Volume: 2014 Topics: Aged, 80 and over; Angiography; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Fatal Outcome; Heart Diseases; Heart Ventricles; Humans; Male; Mesenteric Artery, Superior; Myocardial Infarction; Thromboembolism; Thrombosis; Tomography, X-Ray Computed	2014
Efficacy and cost-effectiveness of dabigatran etexilate versus warfarin in atrial fibrillation in different age subgroups. The American journal of cardiology, 2014, Sep-15, Volume: 114, Issue:6 Topics: Aged; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cost-Benefit Analysis; Dabigatran; Drug Administration Schedule; Drug Costs; Female; Follow-Up Studies; Humans; Incidence; Male; Medicare; Prognosis; Thromboembolism; Time Factors; United States	2014
Peri-procedural interrupted oral anticoagulation for atrial fibrillation ablation: comparison of aspirin, warfarin, dabigatran, and rivaroxaban. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2014, Volume: 16, Issue:10 Topics: Administration, Oral; Aged; Algorithms; Anticoagulants; Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Catheter Ablation; Combined Modality Therapy; Dabigatran; Female; Heparin; Humans; Male; Middle Aged; Morpholines; Postoperative Complications; Radio Waves; Rivaroxaban; Thiophenes; Thromboembolism; Warfarin	2014
Failure of dabigatran and rivaroxaban to prevent thromboembolism in antiphospholipid syndrome: a case series of three patients. Thrombosis and haemostasis, 2014, Volume: 112, Issue:5 Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Benzimidazoles; beta-Alanine; Cerebral Infarction; Dabigatran; Drug Substitution; Female; Humans; International Normalized Ratio; Lupus Erythematosus, Systemic; Male; Mesenteric Veins; Middle Aged; Morpholines; Portal Vein; Recurrence; Retrospective Studies; Rivaroxaban; Splenic Vein; Stroke; Thiophenes; Thromboembolism; Thrombophilia; Treatment Failure; Venous Thrombosis; Warfarin	2014
[New oral anticoagulants are as safe in elderly patients as conventional drugs]. Praxis, 2014, Aug-20, Volume: 103, Issue:17 Topics: Administration, Oral; Age Factors; Aged; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Hemorrhage; Humans; Morpholines; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Stroke; Thiophenes; Thromboembolism; Treatment Outcome	2014
A retrospective descriptive analysis of patient adherence to dabigatran at a large academic medical center. Journal of managed care & specialty pharmacy, 2014, Volume: 20, Issue:10 Topics: Academic Medical Centers; Adult; Aged; Aged, 80 and over; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Female; Hospitalization; Humans; Male; Medication Adherence; Middle Aged; Retrospective Studies; Thromboembolism	2014
Effects of thromboembolism prophylaxis with dabigatran on perioperative blood loss and wound secretion in primary hip arthroplasty. Technology and health care : official journal of the European Society for Engineering and Medicine, 2014, Volume: 22, Issue:6 Topics: Aged; Antithrombins; Arthroplasty, Replacement, Hip; Benzimidazoles; beta-Alanine; Body Fluids; Dabigatran; Female; Humans; Male; Middle Aged; Postoperative Hemorrhage; Thromboembolism	2014
Anticoagulant treatment in German family practices - screening results from a cluster randomized controlled trial. BMC family practice, 2014, Oct-25, Volume: 15 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Coumarins; Dabigatran; Family Practice; Female; Germany; Guideline Adherence; Heart Diseases; Heart Valve Prosthesis; Humans; International Normalized Ratio; Male; Mass Screening; Middle Aged; Morpholines; Practice Guidelines as Topic; Process Assessment, Health Care; Pulmonary Embolism; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Thromboembolism; Thrombosis; Venous Thromboembolism	2014
Safety of dabigatran in an elderly population: single center experience in Italy. Current drug safety, 2015, Volume: 10, Issue:2 Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Cohort Studies; Dabigatran; Female; Fibrinolytic Agents; Heartburn; Hemorrhage; Humans; Italy; Male; Middle Aged; Patient Compliance; Prospective Studies; Registries; Risk Factors; Stroke; Thromboembolism	2015
[Laboratory assessment of haemostatic parameters in patients taking a direct thrombin inhibitor]. Angiologiia i sosudistaia khirurgiia = Angiology and vascular surgery, 2014, Volume: 20, Issue:4 Topics: Aged; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Coagulation; Blood Coagulation Tests; Dabigatran; Dose-Response Relationship, Drug; Drug Monitoring; Female; Follow-Up Studies; Hemorrhage; Humans; Male; Prothrombin; Reproducibility of Results; Risk Assessment; Russia; Stroke; Thromboembolism; Treatment Outcome	2014
The risks of thromboembolism vs. recurrent gastrointestinal bleeding after interruption of systemic anticoagulation in hospitalized inpatients with gastrointestinal bleeding: a prospective study. The American journal of gastroenterology, 2015, Volume: 110, Issue:2 Topics: Aged; Aged, 80 and over; Anticoagulants; Benzimidazoles; beta-Alanine; Cohort Studies; Dabigatran; Enoxaparin; Female; Gastrointestinal Hemorrhage; Heparin; Humans; Ischemic Attack, Transient; Longitudinal Studies; Male; Middle Aged; Morpholines; Patient Readmission; Prospective Studies; Pulmonary Embolism; Pyrazoles; Pyridones; Recurrence; Rivaroxaban; Stroke; Thiophenes; Thromboembolism; Venous Thrombosis; Warfarin; Withholding Treatment	2015
[Extended options of anticoagulant treatment in thromboembolism]. Vnitrni lekarstvi, 2014, Volume: 60, Issue:11 Topics: Administration, Oral; Aged; Antithrombins; Benzimidazoles; beta-Alanine; Czech Republic; Dabigatran; Hemorrhage; Humans; Male; Middle Aged; Morpholines; Pulmonary Embolism; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Thromboembolism; Venous Thrombosis	2014
Novel Oral Anticoagulants for DC Cardioversion Procedures: Utilization and Clinical Outcomes Compared with Warfarin. Pacing and clinical electrophysiology : PACE, 2015, Volume: 38, Issue:6 Topics: Administration, Oral; Aged; Anticoagulants; Dabigatran; Defibrillators, Implantable; Female; Hemorrhage; Humans; Ischemic Attack, Transient; Male; Middle Aged; Postoperative Complications; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thromboembolism; Treatment Outcome; Warfarin	2015
[New oral anticoagulants in venous thromboembolism. General practice information on switching, monitoring, pausing]. MMW Fortschritte der Medizin, 2015, Jan-19, Volume: 157, Issue:1 Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Drug Monitoring; Drug Substitution; Half-Life; Hemorrhage; Humans; Kidney Function Tests; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thiophenes; Thromboembolism; Warfarin	2015
Does the Russell Viper Venom time test provide a rapid estimation of the intensity of oral anticoagulation? A cohort study. Thrombosis research, 2015, Volume: 135, Issue:5 Topics: Administration, Oral; Anticoagulants; Dabigatran; Drug Monitoring; Humans; International Normalized Ratio; Mass Spectrometry; Partial Thromboplastin Time; Prothrombin Time; Retrospective Studies; Rivaroxaban; ROC Curve; Sensitivity and Specificity; Thromboembolism; Time Factors; Vitamin K	2015
[Prospective study of the new oral anticoagulants in private practice: cautious optimism]. Annales de cardiologie et d'angeiologie, 2015, Volume: 64, Issue:2 Topics: Administration, Oral; Anticoagulants; Antithrombins; Cardiology; Cardiovascular Diseases; Dabigatran; Factor Xa Inhibitors; Female; France; General Practice; Humans; Male; Middle Aged; Practice Patterns, Physicians'; Prospective Studies; Pyrazoles; Pyridones; Rivaroxaban; Surveys and Questionnaires; Thromboembolism; Treatment Outcome	2015
Rivaroxaban versus warfarin or dabigatran in patients undergoing catheter ablation for atrial fibrillation: A meta-analysis. International journal of cardiology, 2015, Apr-15, Volume: 185 Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Catheter Ablation; Dabigatran; Factor Xa Inhibitors; Humans; Meta-Analysis as Topic; Rivaroxaban; Thromboembolism; Warfarin	2015
Safety of dabigatran or rivaroxaban for thoracoscopic ablation in patients with atrial fibrillation. International journal of cardiology, 2015, Volume: 186 Topics: Administration, Oral; Antithrombins; Atrial Fibrillation; Catheter Ablation; Dabigatran; Factor Xa Inhibitors; Female; Follow-Up Studies; Humans; Male; Middle Aged; Retrospective Studies; Rivaroxaban; Thoracoscopy; Thromboembolism; Treatment Outcome	2015
[Periprocedural management of anticoagulation in patients undergoing atrial fibrillation ablation]. Revue medicale suisse, 2015, Mar-04, Volume: 11, Issue:464 Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Catheter Ablation; Dabigatran; Humans; Morpholines; Practice Guidelines as Topic; Rivaroxaban; Thiophenes; Thromboembolism	2015
Perioperative Management of Dabigatran: A Prospective Cohort Study. Circulation, 2015, Jul-21, Volume: 132, Issue:3 Topics: Aged; Aged, 80 and over; Antithrombins; Benzimidazoles; beta-Alanine; Cohort Studies; Dabigatran; Disease Management; Female; Hemorrhage; Humans; Male; Middle Aged; Perioperative Care; Prospective Studies; Thromboembolism	2015
Risk of gastrointestinal adverse effects of dabigatran compared with warfarin among patients with atrial fibrillation: a nationwide cohort study. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2015, Volume: 17, Issue:8 Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Causality; Cohort Studies; Comorbidity; Dabigatran; Denmark; Female; Fibrinolytic Agents; Gastrointestinal Diseases; Humans; Incidence; Male; Risk Factors; Survival Rate; Thromboembolism; Treatment Outcome; Warfarin	2015
Is one month treatment with dabigatran before cardioversion of atrial fibrillation sufficient to prevent thromboembolism? Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2015, Volume: 17, Issue:10 Topics: Aged; Anticoagulants; Atrial Fibrillation; Dabigatran; Electric Countershock; Female; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Thromboembolism; Warfarin	2015
Postinterventional use of dabigatran in patients undergoing ablation therapy using an accelerated loading dose scheme - a single center experience. Thrombosis research, 2015, Volume: 136, Issue:2 Topics: Administration, Oral; Antithrombins; Atrial Fibrillation; Catheter Ablation; Chemotherapy, Adjuvant; Dabigatran; Drug Administration Routes; Female; Humans; Male; Middle Aged; Postoperative Hemorrhage; Retrospective Studies; Thromboembolism; Treatment Outcome	2015
Comparison of the short-term risk of bleeding and arterial thromboembolic events in nonvalvular atrial fibrillation patients newly treated with dabigatran or rivaroxaban versus vitamin K antagonists: a French nationwide propensity-matched cohort study. Circulation, 2015, Sep-29, Volume: 132, Issue:13 Topics: Adolescent; Adult; Aged; Anticoagulants; Antithrombins; Arterial Occlusive Diseases; Atrial Fibrillation; Dabigatran; Databases, Factual; Factor Xa Inhibitors; Follow-Up Studies; Hemorrhage; Hospitalization; Humans; Middle Aged; Risk; Rivaroxaban; Thromboembolism; Thrombophilia; Vitamin K; Warfarin; Young Adult	2015
Dabigatran is Less Effective Than Warfarin at Attenuating Mechanical Heart Valve-Induced Thrombin Generation. Journal of the American Heart Association, 2015, Aug-24, Volume: 4, Issue:8 Topics: Anticoagulants; Antithrombins; Dabigatran; Dose-Response Relationship, Drug; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Hemorrhage; Humans; International Normalized Ratio; Kinetics; Prosthesis Design; Thrombin; Thromboembolism; Treatment Outcome; Warfarin	2015
Dabigatran Use Does Not Increase Intracranial Hemorrhage in Traumatic Geriatric Falls When Compared with Warfarin. The American surgeon, 2015, Volume: 81, Issue:10 Topics: Accidental Falls; Aged; Aged, 80 and over; Anticoagulants; Antithrombins; California; Dabigatran; Female; Follow-Up Studies; Glasgow Coma Scale; Humans; Incidence; Intracranial Hemorrhages; Male; Registries; Retrospective Studies; Risk Assessment; Risk Factors; Thromboembolism; Warfarin; Wounds and Injuries	2015
[The Use of Dabigatran for Prevention of Thromboembolic Complications in Patients Underwent Atrial Fibrillation Catheter Ablation]. Kardiologiia, 2015, Volume: 55, Issue:4 Topics: Anticoagulants; Atrial Fibrillation; Catheter Ablation; Dabigatran; Drug Monitoring; Female; Hemorrhage; Humans; Male; Middle Aged; Retrospective Studies; Siberia; Thromboembolism; Treatment Outcome; Warfarin	2015
Effect of standardized perioperative dabigatran interruption on the residual anticoagulation effect at the time of surgery or procedure. Journal of thrombosis and haemostasis : JTH, 2016, Volume: 14, Issue:1 Topics: Aged; Aged, 80 and over; Anticoagulants; Blood Coagulation; Blood Coagulation Tests; Dabigatran; Elective Surgical Procedures; Female; Follow-Up Studies; Hemorrhage; Humans; Male; Middle Aged; Partial Thromboplastin Time; Perioperative Period; Prospective Studies; Prothrombin Time; Risk; Thrombin Time; Thromboembolism; Treatment Outcome	2016
Cardioversion and Risk of Adverse Events with Dabigatran versus Warfarin-A Nationwide Cohort Study. PloS one, 2015, Volume: 10, Issue:10 Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Cohort Studies; Dabigatran; Denmark; Female; Follow-Up Studies; Hospital Administration; Humans; Incidence; Male; Registries; Risk; Thromboembolism; Time Factors; Warfarin	2015
Efficacy and safety of dabigatran in a "real-life" population at high thromboembolic and hemorrhagic risk: data from MonaldiCare registry. European review for medical and pharmacological sciences, 2015, Volume: 19, Issue:20 Topics: Aged; Antithrombins; Atrial Fibrillation; Cohort Studies; Dabigatran; Dyspepsia; Female; Follow-Up Studies; Hemorrhage; Humans; Italy; Male; Middle Aged; Population Surveillance; Prevalence; Prospective Studies; Registries; Risk Factors; Stroke; Thromboembolism; Treatment Outcome	2015
Heart Failure and Mortality in Patients With Nonvalvular Atrial Fibrillation Started on Novel Oral Anticoagulant Therapy: A Single-Center Experience. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2017, Volume: 23, Issue:5 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Dabigatran; Disease-Free Survival; Female; Heart Failure; Humans; Male; Middle Aged; Survival Rate; Thromboembolism	2017
Novel oral anticoagulants and HIV: dabigatran use with antiretrovirals. BMJ case reports, 2015, Nov-20, Volume: 2015 Topics: Anti-HIV Agents; Antithrombins; Atrial Fibrillation; Contraindications; Dabigatran; Drug Administration Schedule; Drug Interactions; HIV Infections; Humans; Male; Middle Aged; Thromboembolism	2015
Impact of Variations in Kidney Function on Nonvitamin K Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Recent Acute Heart Failure. Revista espanola de cardiologia (English ed.), 2016, Volume: 69, Issue:2 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Cardio-Renal Syndrome; Contraindications; Creatinine; Dabigatran; Factor Xa Inhibitors; Female; Humans; Male; Prospective Studies; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thromboembolism	2016
Risk of bleeding and arterial thromboembolism in patients with non-valvular atrial fibrillation either maintained on a vitamin K antagonist or switched to a non-vitamin K-antagonist oral anticoagulant: a retrospective, matched-cohort study. The Lancet. Haematology, 2015, Volume: 2, Issue:4 Topics: Acenocoumarol; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Dabigatran; Female; Hemorrhage; Humans; Male; Phenindione; Retrospective Studies; Risk Factors; Rivaroxaban; Stroke; Thromboembolism; Vitamin K; Warfarin	2015
Novel oral anticoagulants for atrial fibrillation. Singapore medical journal, 2015, Volume: 56, Issue:12 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Cardiology; Dabigatran; Family; Humans; Professional-Patient Relations; Rivaroxaban; Stroke; Thromboembolism; Warfarin	2015
Screening coagulation tests are underutilised in patients on dabigatran presenting with thromboembolic or haemorrhagic events. Internal medicine journal, 2016, Volume: 46, Issue:2 Topics: Aged; Antithrombins; Blood Coagulation Tests; Dabigatran; Female; Hemorrhage; Humans; Male; Middle Aged; Thromboembolism	2016
Urgent surgery or procedures in patients taking dabigatran or warfarin: Analysis of perioperative outcomes from the RE-LY trial. Thrombosis research, 2016, Volume: 139 Topics: Aged; Aged, 80 and over; Ambulatory Care; Anticoagulants; Dabigatran; Female; Hemorrhage; Humans; Male; Perioperative Period; Surgical Procedures, Operative; Thromboembolism; Warfarin	2016
Idarucizumab for Dabigatran Reversal Guideline. Critical pathways in cardiology, 2016, Volume: 15, Issue:2 Topics: Antibodies, Monoclonal, Humanized; Antithrombins; Coagulants; Dabigatran; Drug Monitoring; Hemorrhage; Humans; Thromboembolism	2016
Prediction of rates of thromboembolic and major bleeding outcomes with dabigatran or warfarin among patients with atrial fibrillation: new initiator cohort study. BMJ (Clinical research ed.), 2016, May-24, Volume: 353 Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Cohort Studies; Dabigatran; Female; Hemorrhage; Humans; Incidence; Male; Thromboembolism; United States; Warfarin	2016
Risk of Thromboembolic Events in Patients with Non-Valvular Atrial Fibrillation After Dabigatran or Rivaroxaban Discontinuation - Data from the Ljubljana Registry. PloS one, 2016, Volume: 11, Issue:6 Topics: Aged; Antithrombins; Atrial Fibrillation; Dabigatran; Factor Xa Inhibitors; Female; Humans; Incidence; Male; Registries; Risk Factors; Rivaroxaban; Slovenia; Thromboembolism	2016
Reversal of Dabigatran with Idarucizumab. Expert review of cardiovascular therapy, 2016, Volume: 14, Issue:8 Topics: Antibodies, Monoclonal, Humanized; Anticoagulants; Atrial Fibrillation; Blood Coagulation; Dabigatran; Hemorrhage; Humans; Thromboembolism	2016
Safety of low-dose dabigatran in patients with atrial fibrillation and mild renal insufficiency. Journal of cardiology, 2017, Volume: 69, Issue:3 Topics: Aged; Antithrombins; Atrial Fibrillation; Dabigatran; Drug Administration Schedule; Female; Hemorrhage; Humans; Male; Partial Thromboplastin Time; Renal Insufficiency; Retrospective Studies; Risk Factors; Stroke; Thromboembolism	2017
A solid self-nanoemulsifying system of the BCS class IIb drug dabigatran etexilate to improve oral bioavailability. Nanomedicine (London, England), 2016, Volume: 11, Issue:14 Topics: Administration, Oral; Animals; Antithrombins; Biological Availability; Dabigatran; Emulsions; Excipients; Male; Particle Size; Pharmaceutical Vehicles; Phase Transition; Rats, Sprague-Dawley; Solubility; Stroke; Surface-Active Agents; Thromboembolism	2016
Four-factor prothrombin complex concentrate for life-threatening bleeds or emergent surgery: A retrospective evaluation. Journal of critical care, 2016, Volume: 36 Topics: Aged; Aged, 80 and over; Anticoagulants; Antifibrinolytic Agents; Blood Coagulation Factors; Cardiac Surgical Procedures; Dabigatran; Emergencies; Female; Gastrointestinal Hemorrhage; Heart Transplantation; Hemorrhage; Hemostatics; Heparin; Humans; Incidence; International Normalized Ratio; Intracranial Hemorrhages; Laparotomy; Male; Middle Aged; Preoperative Care; Pyrazoles; Pyridones; Retrospective Studies; Risk Factors; Rivaroxaban; Surgical Procedures, Operative; Thrombocytopenia; Thromboembolism; Vitamin K; Warfarin	2016
Thromboembolic, Bleeding, and Mortality Risks of Rivaroxaban and Dabigatran in Asians With Nonvalvular Atrial Fibrillation. Journal of the American College of Cardiology, 2016, 09-27, Volume: 68, Issue:13 Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Asian People; Atrial Fibrillation; Cohort Studies; Dabigatran; Factor Xa Inhibitors; Female; Gastrointestinal Hemorrhage; Humans; Intracranial Hemorrhages; Male; Middle Aged; Retrospective Studies; Risk Assessment; Rivaroxaban; Stroke; Thromboembolism; Warfarin	2016
A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulants. European heart journal. Cardiovascular pharmacotherapy, 2017, Volume: 3, Issue:1 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Dabigatran; Female; Follow-Up Studies; Hemorrhage; Humans; Incidence; Male; Norway; Prescription Drugs; Pyrazoles; Pyridones; Registries; Retrospective Studies; Rivaroxaban; Survival Rate; Thromboembolism; Warfarin	2017
[Monitoring of NOAC]. Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2017, Volume: 112, Issue:2 Topics: Administration, Oral; Antibodies, Monoclonal, Humanized; Anticoagulants; Blood Coagulation Tests; Dabigatran; Dose-Response Relationship, Drug; Drug Monitoring; Emergency Service, Hospital; Hemorrhage; Humans; Intensive Care Units; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thromboembolism; Vitamin K	2017
[Non-vitamin K dependent oral anticoagulants : What is important in intensive care medicine]. Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2017, Volume: 112, Issue:2 Topics: Antibodies, Monoclonal, Humanized; Anticoagulants; Dabigatran; Electric Countershock; Emergency Service, Hospital; Factor Xa Inhibitors; Hemorrhage; Humans; Intensive Care Units; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thrombin; Thromboembolism; Vitamin K	2017
[Recurrent thromboembolisms despite full anticoagulation in a patient with antiphospholipid syndrome]. Der Internist, 2017, Volume: 58, Issue:7 Topics: Anticoagulants; Antiphospholipid Syndrome; Antithrombins; Dabigatran; Female; Humans; International Normalized Ratio; Lupus Erythematosus, Systemic; Partial Thromboplastin Time; Pulmonary Embolism; Recurrence; Thromboembolism; Venous Thrombosis	2017
Effect of direct oral anticoagulants on the risk of delayed bleeding after gastric endoscopic submucosal dissection. Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society, 2017, Volume: 29, Issue:6 Topics: Administration, Oral; Aged; Anticoagulants; Antithrombins; Blood Transfusion; Cohort Studies; Dabigatran; Endoscopic Mucosal Resection; Female; Follow-Up Studies; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Postoperative Hemorrhage; Retrospective Studies; Risk Factors; Rivaroxaban; Statistics, Nonparametric; Stomach Neoplasms; Thromboembolism; Treatment Outcome; Warfarin	2017
Dabigatran etexilate. Drugs, 2008, Volume: 68, Issue:12 Topics: Anemia; Anticoagulants; Area Under Curve; Benzimidazoles; Dabigatran; Half-Life; Hemorrhage; Humans; Molecular Structure; Platelet Aggregation; Prodrugs; Pyridines; Randomized Controlled Trials as Topic; Suppuration; Surgical Wound Infection; Thromboembolism; Thrombosis; Treatment Outcome	2008
New therapeutic option for thromboembolism--dabigatran etexilate. Expert opinion on pharmacotherapy, 2008, Volume: 9, Issue:14 Topics: Administration, Oral; Anticoagulants; Area Under Curve; Benzimidazoles; Dabigatran; Half-Life; Humans; Male; Pyridines; Thromboembolism	2008
The novel anticoagulants: entering a new era. Swiss medical weekly, 2009, Feb-07, Volume: 139, Issue:5-6 Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles; Dabigatran; Heparin; Heparin, Low-Molecular-Weight; Humans; Morpholines; Orthopedic Procedures; Postoperative Complications; Pyridines; Rivaroxaban; Thiophenes; Thromboembolism; Thrombolytic Therapy; Vitamin K	2009
[New anticoagulants]. Deutsche medizinische Wochenschrift (1946), 2009, Volume: 134, Issue:16 Topics: Acute Coronary Syndrome; Anticoagulants; Antithrombins; Benzimidazoles; Dabigatran; Factor Xa Inhibitors; Humans; Morpholines; Pyridines; Rivaroxaban; Thiophenes; Thromboembolism; Thrombosis	2009
Dabigatran: new drug. Continue to use heparin, a better-known option. Prescrire international, 2009, Volume: 18, Issue:101 Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles; Dabigatran; Drug Approval; Enoxaparin; Factor Xa Inhibitors; Fibrinolytic Agents; France; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Hirudin Therapy; Humans; Prodrugs; Pyridines; Randomized Controlled Trials as Topic; Thrombin; Thromboembolism; Venous Thrombosis; Vitamin K	2009
[Cost-effectiveness analysis of methods for thromboprophylaxis after orthopedic surgery]. Khirurgiia, 2010, Issue:5 Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles; Cost-Benefit Analysis; Dabigatran; Enoxaparin; Female; Health Care Costs; Humans; Male; Postoperative Complications; Pyridines; Thromboembolism; Treatment Outcome	2010
Quality of anticoagulation control in atrial fibrillation. Lancet (London, England), 2010, Sep-18, Volume: 376, Issue:9745 Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; Dabigatran; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hemorrhage; Humans; International Normalized Ratio; Male; Middle Aged; Multicenter Studies as Topic; Pyridines; Quality of Health Care; Randomized Controlled Trials as Topic; Stroke; Thromboembolism; Treatment Outcome; Warfarin	2010
A better blood thinner: news for those with heart rhythm problems. The Johns Hopkins medical letter health after 50, 2011, Volume: 23, Issue:2 Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; Clinical Trials as Topic; Dabigatran; Health Knowledge, Attitudes, Practice; Humans; Patient Education as Topic; Prodrugs; Pyridines; Risk Factors; Thromboembolism	2011
Thromboembolism prophylaxis with dabigatran leads to lower perioperative blood loss than with dalteparin in primary knee arthroplasty. Archives of orthopaedic and trauma surgery, 2011, Volume: 131, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Antithrombin Proteins; Arthroplasty, Replacement, Knee; Benzimidazoles; Blood Loss, Surgical; Case-Control Studies; Dabigatran; Dalteparin; Female; Humans; Male; Middle Aged; Pyridines; Retrospective Studies; Thromboembolism	2011
Dabigatran in atrial fibrillation: pharmacology and clinical trials. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2011, Volume: 32, Issue:3 Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Dabigatran; Dose-Response Relationship, Drug; Evidence-Based Medicine; Humans; Thromboembolism; Treatment Outcome	2011
A new era for anticoagulation in atrial fibrillation. The New England journal of medicine, 2011, Sep-15, Volume: 365, Issue:11 Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Morpholines; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Thromboembolism; Warfarin	2011
Drug-induced exanthem following dabigatran. The Annals of pharmacotherapy, 2011, Volume: 45, Issue:10 Topics: Adult; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Drug Hypersensitivity; Drug Monitoring; Exanthema; Humans; Male; Thromboembolism; Treatment Outcome; Young Adult	2011
The use of dabigatran immediately after atrial fibrillation ablation. Journal of cardiovascular electrophysiology, 2012, Volume: 23, Issue:3 Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Catheter Ablation; Dabigatran; Drug Tolerance; Female; Follow-Up Studies; Glomerular Filtration Rate; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Thrombin; Thromboembolism; Treatment Outcome; Warfarin	2012
UPLC MS/MS assay for routine quantification of dabigatran - a direct thrombin inhibitor - in human plasma. Journal of pharmaceutical and biomedical analysis, 2012, Jan-25, Volume: 58 Topics: Aged; Antithrombins; Benzimidazoles; beta-Alanine; Chromatography, Liquid; Chromatography, Reverse-Phase; Dabigatran; Drug Stability; Humans; Limit of Detection; Reference Standards; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Thromboembolism	2012
Dabigatran: a new oral anticoagulant. Journal of perianesthesia nursing : official journal of the American Society of PeriAnesthesia Nurses, 2011, Volume: 26, Issue:6 Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Stroke; Thromboembolism	2011
[Anticoagulation in atrial fibrillation: a new era has begun]. Hamostaseologie, 2012, Volume: 32, Issue:1 Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Morpholines; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Thromboembolism	2012
[Pharmacologic heterogeneity of new anticoagulants]. Journal des maladies vasculaires, 2011, Volume: 36 Suppl 1 Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles; beta-Alanine; Contraindications; Dabigatran; Drug Approval; Humans; Kidney; Liver; Morpholines; Postoperative Complications; Pulmonary Embolism; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Thromboembolism; United States; United States Food and Drug Administration	2011
Important data after drug approval: comment on "Dabigatran association with higher risk of acute coronary events". Archives of internal medicine, 2012, Mar-12, Volume: 172, Issue:5 Topics: Acute Coronary Syndrome; Benzimidazoles; beta-Alanine; Dabigatran; Female; Humans; Male; Myocardial Infarction; Thromboembolism	2012
Dabigatran: do we have sufficient data?: comment on "Dabigatran association with higher risk of acute coronary events". Archives of internal medicine, 2012, Mar-12, Volume: 172, Issue:5 Topics: Acute Coronary Syndrome; Benzimidazoles; beta-Alanine; Dabigatran; Female; Humans; Male; Myocardial Infarction; Thromboembolism	2012
[Pharmacoeconomic analysis of dabigatran etexilate effectiveness in patients with nonvalvular atrial fibrillation]. Kardiologiia, 2012, Volume: 52, Issue:1 Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Benzimidazoles; Blood Coagulation; Blood Coagulation Tests; Clopidogrel; Costs and Cost Analysis; Dabigatran; Humans; Insurance, Pharmaceutical Services; Models, Statistical; Outcome and Process Assessment, Health Care; Pyridines; Russia; Thromboembolism; Ticlopidine	2012
Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry. Journal of the American College of Cardiology, 2012, Mar-27, Volume: 59, Issue:13 Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Catheter Ablation; Dabigatran; Feasibility Studies; Female; Hemorrhage; Humans; Male; Middle Aged; Perioperative Care; Prospective Studies; Registries; Thromboembolism; Treatment Outcome; Warfarin	2012
[Expanded arsenal in atrial fibrillation: bye-bye marcumar?]. MMW Fortschritte der Medizin, 2012, Jan-19, Volume: 154, Issue:1 Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Drug Approval; Drug Interactions; Drug Substitution; Factor Xa Inhibitors; Germany; Humans; Morpholines; Phenprocoumon; Rivaroxaban; Thiophenes; Thromboembolism	2012
Dabigatran for the prevention of thromboembolic complications in the elderly: a RE-LY-able alternative to warfarin? The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists, 2012, Volume: 27, Issue:6 Topics: Aged; Anticoagulants; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Dabigatran; Fibrinolytic Agents; Humans; Prospective Studies; Stroke; Thromboembolism; Warfarin	2012
Anticoagulation, novel agents, and procedures: can we pardon the interruption? Circulation, 2012, Jul-17, Volume: 126, Issue:3 Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Female; Hemorrhage; Humans; Male; Thromboembolism; Warfarin	2012
Dabigatran: uncharted waters and potential harms. Annals of internal medicine, 2012, Jul-03, Volume: 157, Issue:1 Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Clinical Trials, Phase III as Topic; Dabigatran; Hemorrhage; Humans; Pharmacovigilance; Randomized Controlled Trials as Topic; Thrombin; Thromboembolism; Warfarin	2012
Can dabigatran be an alternative periprocedural anticoagulation for atrial fibrillation ablation? Circulation journal : official journal of the Japanese Circulation Society, 2012, Volume: 76, Issue:10 Topics: Antithrombins; Benzimidazoles; beta-Alanine; Catheter Ablation; Dabigatran; Female; Humans; Male; Perioperative Care; Thromboembolism	2012
[The monitoring of application of dabigatran as a remedy of prevention of thromboembolic complications after hip joint arthroplasty]. Klinicheskaia laboratornaia diagnostika, 2012, Issue:5 Topics: Arthroplasty, Replacement, Hip; Benzimidazoles; beta-Alanine; Dabigatran; Female; Fibrin Fibrinogen Degradation Products; Humans; Male; Middle Aged; Monitoring, Physiologic; Thromboembolism; Whole Blood Coagulation Time	2012
Perioperative management of dabigatran: the Nelson experience to date. The New Zealand medical journal, 2012, Aug-24, Volume: 125, Issue:1360 Topics: Aged; Aged, 80 and over; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Middle Aged; Postoperative Care; Preoperative Care; Surgical Procedures, Operative; Thromboembolism	2012
National trends in oral anticoagulant use in the United States, 2007 to 2011. Circulation. Cardiovascular quality and outcomes, 2012, Sep-01, Volume: 5, Issue:5 Topics: Administration, Oral; Aged; Aged, 80 and over; Ambulatory Care; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Drug Costs; Drug Prescriptions; Drug Utilization; Drug Utilization Review; Guideline Adherence; Health Care Surveys; Health Expenditures; Humans; Medical Audit; Middle Aged; Off-Label Use; Practice Guidelines as Topic; Practice Patterns, Physicians'; Preventive Health Services; Thromboembolism; Time Factors; United States; Warfarin	2012
Catheter ablation of atrial fibrillation: the need for studies to assess the efficacy and safety of novel anticoagulants. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2013, Volume: 36, Issue:1 Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Catheter Ablation; Dabigatran; Humans; Morpholines; Risk Factors; Rivaroxaban; Thiophenes; Thromboembolism; United States; Warfarin	2013
[Antithrombotic prevention in atrial fibrillation: the new anticoagulant drugs]. Giornale italiano di cardiologia (2006), 2012, Volume: 13, Issue:10 Suppl 2 Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Thromboembolism	2012
[Introduction]. Revista clinica espanola, 2012, Volume: 212 Suppl 1 Topics: Acenocoumarol; Anticoagulants; Benzamides; Benzimidazoles; beta-Alanine; Dabigatran; Heparin; Humans; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Thiophenes; Thromboembolism; Thrombosis; Warfarin	2012
[Dabigatran as an alternative to warfarin for the prevention of thromboembolism in atrial fibrillation]. Giornale italiano di cardiologia (2006), 2012, Volume: 13, Issue:11 Suppl 1 Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; Clinical Trials as Topic; Dabigatran; Humans; Pyridines; Thromboembolism; Warfarin	2012
Dabigatran vs warfarin for radiofrequency catheter ablation of atrial fibrillation. Heart rhythm, 2013, Volume: 10, Issue:4 Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Case-Control Studies; Catheter Ablation; Dabigatran; Dose-Response Relationship, Drug; Drug Administration Schedule; Echocardiography, Transesophageal; Electrocardiography; Female; Follow-Up Studies; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Postoperative Care; Predictive Value of Tests; Preoperative Care; Reference Values; Risk Assessment; Severity of Illness Index; Thromboembolism; Treatment Outcome; Warfarin	2013
[Safety and efficacy of various modalities of antiplatelet prophylaxis of ischemic stroke in elderly patients with non-valvular atrial fibrillation]. Klinicheskaia meditsina, 2012, Volume: 90, Issue:10 Topics: Age Factors; Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Brain Ischemia; Clopidogrel; Dabigatran; Female; Hemorrhage; Humans; Male; Platelet Aggregation Inhibitors; Stroke; Thromboembolism; Ticlopidine; Warfarin	2012
Rash associated with dabigatran etexilate. Pharmacotherapy, 2013, Volume: 33, Issue:3 Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; Dabigatran; Drug Eruptions; Exanthema; Humans; Male; Middle Aged; Pyridines; Thromboembolism	2013
Direct thrombin inhibitors. The New England journal of medicine, 2005, Sep-08, Volume: 353, Issue:10 Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Antithrombins; Arginine; Benzimidazoles; Blood Coagulation; Dabigatran; Heart Diseases; Heparin; Humans; Pipecolic Acids; Prodrugs; Pyridines; Sulfonamides; Thrombin; Thromboembolism; Thrombosis; Venous Thrombosis	2005
Effects of the direct thrombin inhibitor dabigatran on ex vivo coagulation time in orthopaedic surgery patients: a population model analysis. British journal of clinical pharmacology, 2006, Volume: 62, Issue:5 Topics: Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Benzimidazoles; Blood Coagulation; Dabigatran; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Pyridines; Thrombin; Thromboembolism	2006